Table of Contents
UNITED STATES OF AMERICA
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended September 30, 2021
OR
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
For the transition period from __________ to __________
Commission File Number: 000-11486
CONNECTONE BANCORP, INC.
(Exact Name of Registrant as Specified in Its Charter)
New Jersey
52-1273725
(State or Other Jurisdiction of
Incorporation or Organization)
(IRS Employer
Identification No.)
301 Sylvan Avenue
Englewood Cliffs, New Jersey 07632
(Address of Principal Executive Offices) (Zip Code)
201-816-8900
(Registrant’s Telephone Number, Including Area Code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading symbol
Name of each exchange on which registered
Common stock
CNOB
NASDAQ
Depositary Shares (each representing a 1/40th interest in a share of 5.25% Series A Non-Cumulative, perpetual preferred stock)
CNOBP
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or emerging growth company. See definition of “large accelerated filer”, “accelerated filer” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act (check one):
Large accelerated filer ☒
Accelerated filer ☐
Non-accelerated filer ☐
(Do not check if smaller
reporting company)
Smaller reporting company ☐
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
Common Stock, no par value:
39,602,199 shares
(Title of Class)
(Outstanding as of November 5, 2021)
Page
PART I – FINANCIAL INFORMATION
3
Item 1.Financial Statements
Consolidated Statements of Condition as of September 30, 2021 (unaudited) and December 31, 2020
Consolidated Statements of Income for the three and nine months ended September 30, 2021 and 2020 (unaudited)
4
Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2021 and 2020 (unaudited)
5
Consolidated Statements of Changes in Stockholders’ Equity for the three and nine months ended September 30, 2021 and 2020 (unaudited)
6
Consolidated Statements of Cash Flows for the nine months ended September 30, 2021 and 2020 (unaudited)
8
Notes to Consolidated Financial Statements (unaudited)
10
2
Item 1. Financial Statements
CONNECTONE BANCORP, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CONDITION
September 30,
December 31,
(in thousands, except for share data)
2021
2020
(unaudited)
ASSETS
Cash and due from banks
$
49,626
63,637
Interest-bearing deposits with banks
363,569
240,119
Cash and cash equivalents
413,195
303,756
Investment securities
462,884
487,955
Equity securities
13,700
13,387
Loans held-for-sale
5,596
4,710
Loans receivable
6,576,439
6,236,307
Less: Allowance for credit losses – loans
77,986
79,226
Net loans receivable
6,498,453
6,157,081
Investment in restricted stock, at cost
18,106
25,099
Bank premises and equipment, net
29,635
30,108
Accrued interest receivable
33,610
35,317
Bank owned life insurance
194,487
165,960
Right of use operating lease assets
11,002
16,159
Goodwill
208,372
Core deposit intangibles
9,480
10,977
Other assets
50,994
88,458
Total assets
7,949,514
7,547,339
LIABILITIES
Deposits:
Noninterest-bearing
1,500,754
1,339,108
Interest-bearing
4,897,584
4,620,116
Total deposits
6,398,338
5,959,224
Borrowings
253,225
425,954
Subordinated debentures, net
152,875
202,648
Operating lease liabilities
12,437
18,026
Other liabilities
34,206
26,177
Total liabilities
6,851,081
6,632,029
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS’ EQUITY
Preferred Stock, no par value;
$1,000 per share liquidation preference; Authorized 5,000,000 shares; issued 115,000 shares as of September 30, 2021 and -0- shares as of December 31, 2020; outstanding 115,000 shares as of September 30, 2021 and -0- shares as of December 31, 2020
110,927
-
Common stock, no par value:
Authorized 100,000,000 shares; issued 42,550,530 shares as of September 30, 2021 and 42,444,031 shares as of December 31, 2020; outstanding 39,602,199 shares as of September 30, 2021 and 39,785,398 as of December 31, 2020
586,946
Additional paid-in capital
25,851
23,887
Retained earnings
413,996
331,951
Treasury stock, at cost 2,948,331 common shares as of September 30, 2021 and 2,658,633 as of December 31, 2020
(38,314
)
(30,271
Accumulated other comprehensive (loss) income
(973
2,797
Total stockholders’ equity
1,098,433
915,310
Total liabilities and stockholders’ equity
See accompanying notes to unaudited consolidated financial statements.
CONSOLIDATED STATEMENTS OF INCOME
Three Months Ended
Nine Months Ended
(in thousands, except for per share data)
Interest income
Interest and fees on loans
75,092
74,755
216,655
223,488
Interest and dividends on investment securities:
Taxable
1,065
1,305
3,148
5,083
Tax-exempt
511
688
1,885
2,148
Dividends
245
426
764
1,268
Interest on federal funds sold and other short-term investments
113
47
246
625
Total interest income
77,026
77,221
222,698
232,612
Interest expense
Deposits
5,478
11,947
19,487
42,756
3,303
4,725
10,794
13,236
Total interest expense
8,781
16,672
30,281
55,992
Net interest income
68,245
60,549
192,417
176,620
Provision for (reversal of) credit losses
1,100
5,000
(6,315
36,000
Net interest income after provision for credit losses
67,145
55,549
198,732
140,620
Noninterest income
Deposit, loan and other income
1,702
1,278
5,092
5,777
Income on bank owned life insurance
1,598
3,527
3,693
Net gains on sale of loans held-for-sale
1,114
614
2,668
1,244
Gain on sale of branches
674
Net (losses) gains on equity securities
(78
(7
(242
215
Net gains on sales/redemption of investment securities
195
29
Total noninterest income
4,016
3,483
11,914
10,958
Noninterest expenses
Salaries and employee benefits
16,807
15,144
47,790
44,266
Occupancy and equipment
2,656
3,566
8,876
10,193
FDIC insurance
525
1,105
2,040
3,054
Professional and consulting
2,217
1,926
6,290
5,173
Marketing and advertising
345
214
864
944
Data processing
1,541
1,470
4,680
4,529
Merger and restructuring expenses
14,640
Amortization of core deposit intangibles
483
627
1,498
1,931
Increase in value of acquisition price
2,333
Other components of net periodic pension expense
(67
(30
(201
(89
Other expenses
3,676
2,456
9,090
7,625
Total noninterest expenses
28,183
26,478
80,927
94,599
Income before income tax expense
42,978
32,554
129,719
56,979
Income tax expense
10,881
7,768
32,404
11,331
Net income
32,097
24,786
97,315
45,648
Earnings per common share:
Basic
0.81
0.62
2.45
1.15
Diluted
0.80
2.43
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in thousands)
Other comprehensive income (loss):
Unrealized gains and losses:
Unrealized holding (losses) gains on available-for-sale securities arising during the period
(3,228
703
(8,397
5,532
Tax effect
796
(160
2,160
(1,459
Net of tax
(2,432
543
(6,237
4,073
Reclassification adjustment for realized gains included in net income
(195
(29
48
(147
(23
Unrealized gains (losses) on cash flow hedges
1,890
(82
1,872
(3,397
(533
42
(529
955
1,357
(40
1,343
(2,442
Reclassification adjustment for realized losses on cash flow hedges included in net income
328
631
1,543
942
(90
(196
(434
(265
238
435
1,109
677
Reclassification adjustment for pension plan amortization included in net income
75
225
226
(21
(63
54
162
163
Total other comprehensive (loss) income
(783
992
(3,770
2,448
Total comprehensive income
31,314
25,778
93,545
48,096
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
Nine Months Ended September 30, 2021
(dollars in thousands, except for per share data)
Preferred
Stock
Common
Additional
Paid-In
Capital
Retained
Earnings
Treasury
Accumulated
Other
Comprehensive
(Loss) Income
Total
Stockholders’
Equity
Balance as of December 31, 2020
Cumulative effect of change in accounting principle (see note 1b. “Authoritative Accounting Guidance Presentation”), net of tax
(2,925
Balance as of January 1, 2021, as adjusted for changes in accounting principle
329,026
912,385
Other comprehensive loss, net of tax
Cash dividends declared on common stock ($0.31 per share)
(12,345
Exercise of stock options (5,449 shares)
45
Restricted stock grants, net of forfeitures (46,900 shares)
Stock grants (4,981 shares)
Net shares issued in satisfaction of restricted stock units earned (14,711 shares)
Net shares issued in satisfaction of performance units earned (34,458 shares)
Share redemption for tax withholdings on performance units and restricted stock units earned
(1,283
Repurchase of treasury stock (289,698 shares)
(8,043
Proceeds from preferred stock issuance, net of costs (115,000 shares)
Stock-based compensation expense
3,202
Balance as of September 30, 2021
Three Months Ended September 30, 2021
Balance as of June 30, 2021
24,606
386,280
(32,682
(190
964,960
Cash dividends declared on common stock ($0.11 per share)
(4,381
Restricted stock grants, net of forfeitures (1,082 shares)
Stock grants (4,535 shares)
Repurchase of treasury stock (196,069 shares)
(5,632
1,245
(continued)
Nine Months Ended September 30, 2020
Balance as of December 31, 2019
468,571
21,344
271,782
(29,360
(1,147
731,190
Other comprehensive income, net of tax
Cash dividends declared on common stock ($0.18 per share)
(7,537
Exercise of stock options (25,413 shares)
Restricted stock grants, net of forfeitures (68,531 shares)
Stock grants issued (1,340 shares)
Net shares issued in satisfaction of restricted stock units earned
(16,541 shares)
Net shares issued in satisfaction of performance units earned (22,402 shares)
(639
Repurchase of treasury stock (54,693 shares)
(911
Stock issued (4,602,450 shares) in acquisition of Bancorp of New Jersey
118,375
1,999
Balance as of September 30, 2020
22,867
309,893
1,301
890,736
Three Months Ended September 30, 2020
Balance as of June 30, 2020
22,069
288,688
309
867,741
Cash dividends declared on common stock ($0.09 per share)
(3,581
Restricted stock grants, net of forfeitures (1,018 shares)
798
7
CONSOLIDATED STATEMENTS OF CASH FLOWS
(dollars in thousands)
Cash flows from operating activities
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of premises and equipment
2,832
3,102
(Reversal of) provision for credit losses
Amortization of intangibles
Net accretion of loans
(4,130
(5,225
Accretion on bank premises
(61
(68
Accretion on deposits
(1,762
(3,568
Accretion on borrowings, net
(43
(139
Stock-based compensation
Gains on sales/redemptions of securities available-for-sale, net
Losses (gains) on equity securities, net
242
(215
(674
Net losses on disposition of fixed assets
65
Gains on sales of loans held-for-sale, net
(2,668
(1,244
Loans originated for resale
(43,676
(34,328
Proceeds from sale of loans held-for sale
57,674
51,367
Gain on sale of other real estate owned
(18
Increase in cash surrender value of bank owned life insurance
(3,527
(3,693
Amortization of premiums and accretion of discounts on securities available-for-sale, net
4,677
4,000
Amortization of subordinated debentures issuance costs
227
247
Decrease (increase) in accrued interest receivable
1,707
(10,467
Net change in operating leases
(734
2,071
Decrease in other assets
43,319
18,117
Increase (decrease) in other liabilities
5,689
(5,750
Net cash provided by operating activities
154,644
99,756
Cash flows from investing activities
Investment securities available-for-sale:
Purchases
(203,534
(222,062
Sales
19,624
Maturities, calls and principal repayments
215,531
175,729
Purchases of equity securities
(555
(2,000
Net redemptions of restricted investment in bank stocks
6,993
1,748
Net increase in loans
(345,098
(348,861
Purchases of bank owned life insurance
(25,000
Purchases of premises and equipment
(2,473
(894
Payments on loans held-for-sale
32
204
Proceeds from life insurance death benefits
978
Proceeds from sale of branches
1,087
Proceeds from sale of other real estate owned
321
Cash and cash equivalents acquired in acquisition, net
87,391
Net cash used in investing activities
(352,696
(312,151
Cash flows from financing activities
Net increase in deposits
440,876
249,404
(Repayment of) increase in subordinated debentures
(50,000
73,420
Advances of borrowings
100,000
1,476,489
Repayments of borrowings
(272,686
(1,520,160
Repurchase of common stock to treasury
Net proceeds from the issuance of preferred stock
Cash dividends paid on common stock
(10,735
Proceeds from exercise of stock options
Net cash provided by financing activities
307,491
267,031
Net change in cash and cash equivalents
109,439
54,636
Cash and cash equivalents at beginning of period
201,483
Cash and cash equivalents at end of period
256,119
Supplemental disclosures of cash flow information
Cash payments for:
Interest paid on deposits and borrowings
32,664
59,231
Income taxes
35,809
19,117
Supplemental disclosures of noncash activities
Investing:
Transfer of loans from held-for-investment to other real estate owned
304
Transfer of loans from held-for-investment to held-for-sale
14,211
10,995
Transfer of loans from held-for-sale to held-for-investment
1,963
19,738
Business combinations:
Fair value of assets acquired
949,282
Fair value of liabilities assumed
852,729
9
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note 1a. Nature of Operations, Principles of Consolidation and Risk and Uncertainties
Nature of Operations
ConnectOne Bancorp, Inc. (the “Parent Corporation”) is incorporated under the laws of the State of New Jersey and is a registered bank holding company under the Bank Holding Company Act of 1956, as amended (the “BHCA”). The Parent Corporation’s business currently consists of the operation of its wholly-owned subsidiary, ConnectOne Bank (the “Bank” and, collectively with the Parent Corporation and the Parent Corporation’s subsidiaries, the “Company”). The Bank’s subsidiaries include Union Investment Co. (a New Jersey investment company), Twin Bridge Investment Co. (a New Jersey investment company), ConnectOne Preferred Funding Corp. (a New Jersey real estate investment trust), Center Financial Group, LLC (a New Jersey financial services company), Center Advertising, Inc. (a New Jersey advertising company), Morris Property Company, LLC, (a New Jersey limited liability company), Volosin Holdings, LLC, (a New Jersey limited liability company), NJCB Spec-1, LLC (a New Jersey limited liability company), Port Jervis Holdings, LLC (a New Jersey limited liability company), BONJ Special Properties, LLC (a New Jersey limited liability company) and BoeFly, Inc. (a New Jersey financial technology company).
The Bank is a community-based, full-service New Jersey-chartered commercial bank that was founded in 2005. The Bank operates from its headquarters located at 301 Sylvan Avenue in the Borough of Englewood Cliffs, Bergen County, New Jersey and through its twenty-five other banking offices. Substantially all loans are secured with various types of collateral, including business assets, consumer assets and commercial/residential real estate. Each borrower’s ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers’ business, real estate rental and consumer wages.
The preceding unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X, and, accordingly, do not include all of the information and footnotes required by GAAP for complete financial statements. However, in the opinion of management, all adjustments (consisting only of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected for the full year ending December 31, 2021, or for any other interim period. The Company’s 2020 Annual Report on Form 10-K should be read in conjunction with these consolidated financial statements.
Basis of Presentation
The consolidated financial statements have been prepared in conformity with GAAP. Some items in the prior year consolidated financial statements were reclassified to conform to current presentation. Reclassifications had no effect on prior year net income or stockholders’ equity.
Use of Estimates
In preparing the consolidated financial statements, management has made estimates and assumptions that affect the reported amounts of assets and liabilities as of the dates of the consolidated statements of condition and that affect the results of operations for the periods presented. Actual results could differ significantly from those estimates.
Risks and Uncertainties
As previously disclosed, on March 11, 2020 the World Health Organization declared the outbreak of COVID-19 as a global pandemic, which continues to impact the United States and the world. On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was enacted to, among other things, provide emergency assistance for individuals, families and businesses affected by the COVID-19 pandemic. The COVID-19 pandemic has adversely affected, and continues to adversely affect economic activity globally, nationally and locally. Actions taken around the world to help mitigate the spread of COVID-19 include restrictions on travel, quarantines in certain areas, and forced closures for certain types of public places and businesses. Although economic activity has accelerated in 2021, and the United States continues to implement a COVID-19 vaccination program, COVID-19, it’s variants and actions taken to mitigate the spread of it have had and may in the future have an adverse impact on the economies and financial markets of many countries and parts of the United States, including the New Jersey/New York metropolitan area in which the Company primarily operates. Although the Company has been able to continue operations while taking steps to ensure the safety of employees and customers, COVID-19 could impact the Company’s operations in the future. Federal Reserve reductions in interest rates and other effects of the COVID-19 pandemic may adversely affect the Company's financial condition and results of operations in future periods. Although state and local governments have lifted many restrictions on conducting business, it is possible that restrictions could be reimposed. It is therefore unknown how long COVID-19 may continue to impact the economy and what the complete financial effect will be to the Company. It is reasonably possible that estimates made in the financial statements could be materially and adversely impacted in the near term as a result of these conditions, including the determination of the allowance for credit losses on loans, fair value of financial instruments, impairment of goodwill and other intangible assets and income taxes.
Note 1b. Authoritative Accounting Guidance
Adoption of New Accounting Standards in 2021
Effective January 1, 2021, the Company adopted Accounting Standards Update (“ASU”) 2016-13 “ASU 2016-13 Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments”, which replaced the prior incurred loss methodology with an expected loss methodology that is referred to as the current expected credit loss (“CECL” or the “CECL Standard”). The measurement of expected credit losses under the CECL Standard is applicable to financial assets measured at amortized cost, including portfolio loans and investment securities classified as held-to-maturity (“HTM”). It also applies to off-balance sheet credit exposures including loan commitments, standby letters of credit, financial guarantees and other similar instruments. In addition, the CECL Standard changes the accounting for investment securities classified as available-for-sale (“AFS”), including a requirement that estimated credit losses on AFS securities be presented as an allowance rather than as a direct write-down of the carrying balance of securities which we do not intend to sell, or believe that it is more likely than not, that we will be required to sell.
The Company adopted the CECL Standard using the modified retrospective method for all financial assets measured at amortized cost and off-balance sheet credit exposures. As discussed further below, purchased credit deteriorated assets were measured on a prospective basis in accordance with the CECL Standard and all purchased credit impaired loans as of December 31, 2020 were considered purchased credit deteriorated loans upon adoption. Results for reporting periods beginning after January 1, 2021 are presented under the CECL Standard while prior period amounts continue to be reported in accordance with previously applicable accounting guidance. The adoption of the CECL Standard resulted in the following adjustments to our financial statements as of January 1, 2021 (dollars in thousands):
Change in Consolidated
Change to Retained Earnings
Statement of Condition
Tax Effect
from Adoption of CECL
Allowance for credit losses (“ACL”) (loans)
1,350
406
Adjustment related to purchased credit-impaired loan marks(1)
5,207
Total ACL – loans
6,557
ACL (unfunded credit commitments)
2,833
852
1,981
Total impact of CECL adoption
9,390
1,258
2,925
(1)
This amount represents a gross-up of the balance sheet related to nonaccretable credit marks of purchased credit-impaired loans resulting from adoption of CECL on January 1, 2021.
Loans designated as purchased credit impaired loans (“PCI”) and accounted for under Accounting Standards Codification (“ASC”) 310-30 were designated as purchased with credit deterioration loans (“PCD”). In accordance with the CECL Standard, the Company did not reassess whether PCI loans met the criteria of PCD loans as of the date of adoption and determined all PCI loans were PCD loans. The Company recorded an increase to the balance of PCD loans and an increase to the ACL for loans of $5.2 million, which represented the expected credit losses for PCD loans. The remaining non-credit discount (based on the adjusted amortized cost basis) will be accreted into interest income at the effective interest rate as of January 1, 2021 over the remaining estimated life of the loans. Also, in accordance with the CECL Standard, the Company did not reassess whether modifications to individual acquired financial assets were troubled debt restructurings (“TDRs”) as of the date of adoption.
ACL for loans: The ACL for loans is a valuation account that is deducted from the amortized cost basis of portfolio loans to present the net amount expected to be collected on portfolio loans over their contractual life. Loans are charged-off against the allowance when we believe the uncollectibility of a loan balance has been confirmed, and the expected recoveries do not exceed the aggregate of amounts previously charged-off or expected to be charged-off.
11
Note 1b. Authoritative Accounting Guidance – (continued)
The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The Company currently utilizes a one-year reasonable and supportable forecast period followed by a one-year period over which estimated losses revert to historical loss experience for the remaining life of the loan. The measurement of expected credit loss under the CECL methodology is applicable to financial assets measured at amortized cost, including loans and held to maturity investments and it also applies to certain off-balance sheet credit exposures.
The ACL for loans is measured on a collective (pool) basis when similar risk characteristics exist. Generally, for all other loan types, the estimated expected credit loss is also calculated at the loan level and pool assignments are only utilized for aggregating the allowance estimates of similar loan types for financial statement disclosure purposes. Loan segments have unique risk characteristics with respect to credit quality and are as follows:
●
The repayment of commercial loans is generally dependent on the creditworthiness and cash flow of borrowers, and if applicable, guarantors, which may be negatively impacted by adverse economic conditions. While the majority of these loans are secured, collateral type, marketing, coverage, valuation and monitoring are not as uniform as in other portfolio classes and recovery from liquidation of such collateral may be subject to greater variability.
Payment on commercial mortgages is driven principally by operating results of the managed properties or underlying business and secondarily by the sale or refinance of such properties. Both primary and secondary sources of repayment, and value of the properties in liquidation, may be affected to a greater extent by adverse conditions in the real estate market or the economy in general.
Properties underlying construction, land and land development loans often do not generate sufficient cash flows to service debt and thus repayment is subject to the ability of the borrower and, if applicable, guarantors, to complete development or construction of the property and carry the project, often for extended periods of time. As a result, the performance of these loans is contingent upon future events whose probability at the time of origination is uncertain.
The ability of borrowers to service debt in the residential and consumer loan portfolios is generally subject to personal income which may be impacted by general economic conditions, such as increased unemployment levels. These loans are predominately collateralized by first and/or second liens on single family properties. If a borrower cannot maintain the loan, the Company’s ability to recover against the collateral in sufficient amount and in a timely manner may be significantly influenced by market, legal and regulatory conditions.
The Company considers loan classes and loan segments to be one and the same.
Individually Analyzed Loans: The Company will evaluate individual instruments for expected credit losses when those instruments do not share similar risk characteristics with instruments evaluated using a collective (pooled) basis. Loans will transition from defined segments for individual analysis when credit characteristics, or risk traits, change in a material manner. A loan is considered for individual analysis when, based on current information and events, it is probable that the Bank will be unable to collect the scheduled payments of principal or interest when due according to the contractual terms of the loan agreement. Factors considered by management in determining individual analysis include payment status and the probability of collecting scheduled principal and interest payments when due. Loans for which the terms have been modified as a concession to the borrower due to the borrower experiencing financial difficulties are considered TDRs and are classified as individually analyzed. Loans considered to be TDRs can be categorized as nonaccrual or performing. All PCD loans will be considered as individually analyzed. Generally, individually analyzed loans consist of nonaccrual loans and performing TDRs. Of this group of loans, loans of $250,000 and over are individually evaluated, while loans with balances less than $250,000 are collectively evaluated, and, accordingly, are not separately identified for analysis or disclosures. Instruments will not be included in both collective and individual analysis. Individual analysis will establish a specific reserve for instruments in scope.
For collateral dependent loans, when it is determined that a foreclosure is probable, the ACL will be determined on a loan level basis using the fair value of the collateral as of the reporting date, less estimated disposition costs (“net fair value”), which will ensure that the credit loss is not delayed until the time at which the actual foreclosure takes place. In the event that this fair value is less than the amortized cost basis of these specific loans, we will recognize the difference between the net fair value at the reporting date and the amortized cost basis in the ACL. If the fair value of the collateral has increased as of the ACL evaluation date, the increase in the fair value of the collateral is reflected through a reduction in the ACL. ACL adjustments for estimated disposition costs are not appropriate when the repayment of a collateral-dependent loan is expected from the operation of the collateral. If repayment is based upon future expected cash flows, the present value of the expected future cash flows discounted at the loan’s original effective interest rate is compared to the carrying value of the loan, and any shortfall is recorded as the allowance for credit losses. The effective interest rate used to discount expected cash flows is adjusted to incorporate expected prepayments, if applicable.
12
For charge-offs and recoveries we will generally charge-off a loan balance after an analysis is completed which indicates that the collectability of the full principal is in doubt. Charge-offs are charged against the allowance in the period in which the loans are deemed to be uncollectible. Any expected future recoveries of amounts which were previously charged-off or expected to be charged-off will be included in the ACL, as the recoveries represent a component of the net amount expected to be collected. Expected recoveries in the ACL shall not exceed amounts previously charged-off or expected to be charged-off.
Investment Securities: Securities available-for-sale are carried at fair value, with unrealized holding gains and losses reported in comprehensive income, net of tax. Interest income includes amortization of purchase premiums or discounts. Premiums and discounts on securities are generally amortized using the level-yield method without estimating prepayments, except for mortgage-backed securities, where prepayment rates are estimated. Premiums on callable investment securities are amortized to their earliest call date. Gains and losses on sales of securities are recorded on the trade date and determined using the specific identification method.
ACL - on investment securities classified as available-for-sale: For available-for-sale investment securities which are in an unrealized loss position, the Company will first assess whether we intend to sell, or it is more likely than not, that we will be required to sell the security before recovery of the amortized cost basis. If either of the criteria is met, the amortized cost basis of the security is written down to fair value through income. For available-for-sale investment securities that do not meet the aforementioned criteria, we evaluate whether the decline in fair value has resulted from an actual or estimated credit loss event or other factors. In making this assessment, we consider the extent to which fair value is less than amortized cost, changes to the rating of the security, and adverse conditions specifically related to the security, among other factors. If this assessment indicates that a credit loss is likely, the present value of cash flows expected to be collected from the security are compared to the amortized cost basis of the security. If the present value of the cash flows expected to be collected is less than the amortized cost basis, an ACL is recorded for the estimated credit loss, limited by the amount that the fair value is less than the amortized cost basis. Any impairment that has not been recorded through an ACL is recognized in other comprehensive income.
Changes in the ACL are recorded as provision for (or reversal of) credit loss expense. Losses are charged against the allowance when we believe the uncollectibility of an available-for-sale security has been confirmed or if either of the criteria regarding intent or requirement to sell is met.
ASU No. 2021-03, “Intangibles – Goodwill and Other (Topic 350).” ASU 2021-03 requires an entity to identify and evaluate goodwill impairment triggering events when they occur to determine whether it is more likely than not that the fair value of a reporting unit (or entity, if the entity has elected the accounting alternative for amortizing goodwill and chosen that option) is less than its carrying amount. If an entity determines that it is more likely than not that the goodwill is impaired. It must test goodwill for impairment using the triggering event date as the measurement date. An entity is required to disclose the amount assigned to goodwill in total and by major business combination, or by reorganization event resulting in fresh-start reporting. Also, the entity must disclose the weighted average amortization period in total and the amortization period by major business combination, or by reorganization event resulting in fresh-start reporting. ASU 2021-03 was effective for the Company on January 1, 2021 and did not have a significant impact on our consolidated financial statements.
ASU 2018-14, “Compensation—Retirement Benefits—Defined Benefit Plans—General (Subtopic 715-20): Disclosure Framework—Changes to the Disclosure Requirements for Defined Benefit Plans.” These amendments modify the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans. ASU 2018-14 was effective for the Company as of January 1, 2021 and did not have a significant impact on our consolidated financial statements.
13
Note 2. Earnings per Common Share
Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) No. 260-10-45 addresses whether instruments granted in share-based payment transactions are participating securities prior to vesting and, therefore, need to be included in the earnings allocation in computing earnings per share (“EPS”). The restricted stock awards granted by the Company contain non-forfeitable rights to dividends and therefore are considered participating securities. The two-class method for calculating basic EPS excludes dividends paid to participating securities and any undistributed earnings attributable to participating securities.
Earnings per common share have been computed based on the following:
Earnings allocated to participating securities
(76
(133
(250
(218
Income attributable to common stock
32,021
24,653
97,065
45,430
Weighted average common shares outstanding, including participating securities
39,741
39,656
39,770
39,624
Weighted average participating securities
(95
(119
(102
(125
Weighted average common shares outstanding
39,646
39,537
39,668
39,499
Incremental shares from assumed conversions of options, performance units and non-participating restricted shares
223
117
220
111
Weighted average common and equivalent shares outstanding
39,869
39,654
39,888
39,610
There were no antidilutive share equivalents as of September 30, 2021 and September 30, 2020.
14
Note 3. Investment Securities
The Company’s investment securities are all classified as available-for-sale as of September 30, 2021 and December 31, 2020. Investment securities available-for-sale are reported at fair value with unrealized gains or losses included in stockholders’ equity, net of tax. Accordingly, the carrying value of such securities reflects their fair value as of September 30, 2021 and December 31, 2020. Fair value is based upon either quoted market prices, or in certain cases where there is limited activity in the market for a particular instrument, assumptions are made to determine their fair value. See Note 6 of the Notes to Consolidated Financial Statements for a further discussion.
The following tables present information related to the Company’s portfolio of securities available-for-sale as of September 30, 2021 and December 31, 2020.
Allowance
for
Gross
Investment
Amortized
Unrealized
Fair
Credit
Cost
Gains
Losses
Value
September 30, 2021
Securities available-for-sale
Federal agency obligations
50,016
1,032
51,048
Residential mortgage pass-through securities
255,488
2,640
(2,073
256,055
Commercial mortgage pass-through securities
10,859
135
(468
10,526
Obligations of U.S. states and political subdivisions
129,632
1,693
(1,051
130,274
Corporate bonds and notes
10,965
124
11,089
Asset-backed securities
2,718
(2
2,722
Certificates of deposit
149
1
150
Other securities
1,020
Total securities available-for-sale
460,847
5,631
(3,594
December 31, 2020
37,015
1,508
(65
38,458
N/A
266,114
4,811
(41
270,884
6,906
203
(187
6,922
138,539
4,269
142,808
24,925
222
(52
25,095
3,521
3,480
151
157
477,326
11,015
(386
15
Note 3. Investment Securities – (continued)
Investment securities having a carrying value of approximately $88.1 million and $107.6 million as of September 30, 2021 and December 31, 2020, respectively, were pledged to secure public deposits, borrowings, repurchase agreements, Federal Reserve Discount Window borrowings and Federal Home Loan Bank advances and for other purposes required or permitted by law. As of September 30, 2021 and December 31, 2020, there were no holdings of securities of any one issuer, other than the U.S. Government and its agencies, in an amount greater than 10% of stockholders’ equity.
The following table presents information for investments in securities available-for-sale as of September 30, 2021, based on scheduled maturities. Actual maturities can be expected to differ from scheduled maturities due to prepayment or early call options of the issuer. Securities not due at a single maturity date are shown separately.
Securities available-for-sale:
Due in one year or less
4,439
4,451
Due after one year through five years
9,911
10,024
Due after five years through ten years
7,777
8,029
Due after ten years
171,353
172,779
Total securities available-for-sale
Gross gains and losses from the sales and redemptions of securities for periods presented were as follows:
Proceeds
5,185
Gross gains on sales/redemption of securities
Gross losses on sales/redemptions of securities
Net gains on sales/redemptions of securities
Less: tax provision on net gains
(48
(6
Net gains on sales/redemptions of securities, after tax
147
23
16
Impairment Analysis of Available-for-Sale Debt Securities
The following tables indicate gross unrealized losses for which an ACL has not been recorded, aggregated by investment category and by the length of continuous time individual securities have been in an unrealized loss position as of September 30, 2021 and December 31, 2020.
Less than 12 Months
12 Months or Longer
Investment Securities
Available-for-Sale:
171,592
6,349
2,658
3,691
(401
71,938
1,389
840
549
Total temporarily impaired securities
251,268
247,028
(3,191
4,240
(403
8,978
8,975
20,895
20,886
3,954
3,928
3,083
622
2,461
Total Temporarily Impaired Securities
40,838
38,365
(345
2,473
17
On January 1, 2021, the Company adopted ASU 2016-13 and implemented the CECL methodology for allowance for credit losses on its investment securities available-for-sale. The new CECL methodology replaces the other-than-temporary impairment model that previously existed. The Company did not have a CECL day 1 impact attributable to its investment securities portfolio and did not have an allowance for credit losses as of September 30, 2021. The Company has elected to exclude accrued interest from the amortized cost of its investment securities available-for-sale. Accrued interest receivable for investment securities available for sale as of September 30, 2021 and December 31, 2020, totaled $1.4 million and $1.7 million, respectively.
The Company evaluates securities in an unrealized loss position for impairment related to credit losses on at least a quarterly basis. Securities in unrealized loss positions are first assessed as to whether we intend to sell, or if it is more likely than not that we will be required to sell the security before recovery of its amortized cost basis. If one of the criteria is met, the security’s amortized cost basis is written down to fair value through current earnings. For securities that do not meet these criteria, the Company evaluates whether the decline in fair value resulted from credit losses or other factors. If this assessment indicates that a credit loss exists, we compare the present value of cash flows expected to be collected from the security with the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis for the security, a credit loss exists and an allowance for credit losses is recorded, limited to the amount that the fair value of the security is less than its amortized cost basis. Unrealized losses on asset backed securities and state and municipal securities have not been recognized into income because the issuers are of high credit quality, we do not intend to sell and it is likely that we will not be required to sell the securities prior to their anticipated recovery. The decline in fair value is largely due to changes in interest rates and other market conditions. The issuers continue to make timely principal and interest payments on the securities. Any impairment that has not been recorded through an allowance for credit losses is recognized in other comprehensive income, net of applicable taxes. No allowance for credit losses for available-for-sale securities was recorded as of September 30, 2021.
Federal agency obligations, residential mortgage-backed pass-through securities and commercial mortgage-backed pass-through securities are issued by U.S. Government agencies and U.S. Government sponsored enterprises. Although a government guarantee exists on these investments, these entities are not legally backed by the full faith and credit of the federal government, and the current support they receive is subject to a cap as part of the agreement entered into in 2008. Nonetheless, at this time we do not foresee any set of circumstances in which the government would not fund its commitments on these investments as the issuers are an integral part of the U.S. housing market in providing liquidity and stability. Therefore, we concluded that a zero-allowance approach for these investment securities is appropriate.
Note 4. Derivatives
The Company utilizes interest rate swap agreements as part of its asset liability management strategy to help manage its interest rate risk position. The notional amount of the interest rate swap does not represent amounts exchanged by the parties. The amount exchanged is determined by reference to the notional amount and the other terms of the individual interest rate swap agreements. Interest rate swaps were entered into on April 13, 2017, January 1, 2020 and March 3, 2020 each with a respective notional amount of $25.0 million and were designated as a cash flow hedge of a Federal Home Loan Bank advance We are required to pay fixed-rates of interest ranging from 0.88% to 1.93% and receive variable rates of interest that reset quarterly based on three-month LIBOR. Expiration dates for the swaps range from January 2022 to April 2022. The swaps were determined to be fully effective during the period presented and therefore no amount of ineffectiveness has been included in net income. Therefore, the aggregate fair value of the swaps is recorded in other assets (liabilities) with changes in fair value recorded in other comprehensive income (loss). The amount included in accumulated other comprehensive income (loss) would be reclassified to current earnings should the hedges no longer be considered effective. The Company expects the hedges to remain fully effective during the remaining term of the swaps.
In addition, during the three months ended September 30, 2021, the company entered into 5 forward starting pay fixed-rate interest rate swaps, with a total notional amount of $200 million, which are also designated as a cash flow hedge of a future Federal Home Loan Bank advance. We are required to pay fixed rates of interest ranging from 0.631% to 0.955% and receive variable rates of interest that reset quarterly based on the daily compounding secured overnight financing rate (“SOFR”). The forward starting swaps have commencing payment dates ranging from October 2021 to April 2022, with expiration dates ranging from March 2026 to January 2028.
18
Note 4. Derivatives – (continued)
Interest expense recorded on these swap transactions totaled approximately $0.3 million and $1.5 million during the three and nine months ended September 30, 2021, respectively, compared to $0.6 million and $0.9 million during the three and nine months ended September 30, 2020, respectively, and is reported as a component of interest expense on FHLB Advances.
Cash Flow Hedge
The following table presents the net losses recorded in other comprehensive income and the Consolidated Statements of Income relating to the cash flow derivative instruments for the following periods:
Amount of (loss)
Amount of loss
Amount of gain
gain recognized
(gain) reclassified
recognized in other
in OCI (Effective
from OCI to
Portion)
interest income
(Ineffective Portion)
Interest rate contracts
19
The following table reflects the cash flow hedges included in the consolidated statements of condition as of September 30, 2021 and December 31, 2020:
Notional
Amount
Fair Value
Interest rate swaps related to FHLB advances included in liabilities
275,000
1,295
175,000
(2,119
20
Note 5. Loans and the Allowance for Credit Losses
Loans Receivable - As of and prior to December 31, 2020, loans receivable were accounted for under the incurred loss model. As of January 1, 2021, portfolio loans are accounted for under the expected loss model. Accordingly, some of the information presented is not comparable from period to period. See Note 1b. “Authoritative Accounting Guidance - Adoption of New Accounting Standards” for additional information. The following table sets forth the composition of the Company’s loan portfolio segments, including net deferred fees, as of September 30, 2021 and December 31, 2020:
Commercial (1)
1,325,488
1,521,967
Commercial real estate
4,436,626
3,783,550
Commercial construction
552,896
617,747
Residential real estate
270,793
322,564
Consumer
2,093
1,853
Gross loans
6,587,896
6,247,681
Net deferred loan fees
(11,457
(11,374
Total loans receivable
Included in commercial loans as of September 30, 2021 and December 31, 2020 were PPP loans of $177.8 million and $397.5 million, respectively.
As of each of September 30, 2021 and December 31, 2020, loan balances of approximately $2.6 billion, were pledged to secure borrowings from the FHLB of New York.
Loans held-for-sale - The following table sets forth the composition of the Company’s loans held-for-sale portfolio as of September 30, 2021 and December 31, 2020:
4,876
1,990
720
2,720
Total carrying amount
Loans Receivable on Nonaccrual Status - The following tables present nonaccrual loans with an ACL as of September 30, 2021 and nonaccrual loans without an ACL as of September 30, 2021:
Nonaccrual
loans with
ACL
loans without
loans
Commercial
27,993
2,486
30,479
11,668
16,910
28,578
3,336
39,661
26,298
65,959
21
Note 5. Loans and the Allowance for Credit Losses – (continued)
The following tables present total nonaccrual loans included in loans receivable by loan class as of December 31, 2020 (dollars in thousands):
33,019
10,111
14,015
4,551
Total nonaccrual loans
61,696
Nonaccrual loans include both smaller balance homogeneous loans that are collectively evaluated for impairment and loans individually evaluated for impairment.
Credit Quality Indicators - The Company continuously monitors the credit quality of its loans receivable. In addition to its internal monitoring, the Company utilizes the services of a third-party loan review firm to periodically validate the credit quality of its loans receivable on a sample basis. Credit quality is monitored by reviewing certain credit quality indicators. Assets classified as “Pass” are deemed to possess average to superior credit quality, requiring no more than normal attention. Assets classified as “Special Mention” have generally acceptable credit quality yet possess higher risk characteristics/circumstances than satisfactory assets. Such conditions include strained liquidity, slow pay, stale financial statements, or other conditions that require more stringent attention from the lending staff. These conditions, if not corrected, may weaken the loan quality or inadequately protect the Company’s credit position at some future date. Assets are classified as “Substandard” if the asset has a well-defined weakness that requires management’s attention to a greater degree than for loans classified as special mention. Such weakness, if left uncorrected, could possibly result in the compromised ability of the loan to perform to contractual requirements. An asset is classified as “Doubtful” if it is inadequately protected by the net worth and/or paying capacity of the obligor or of the collateral, if any, that secures the obligation. Assets classified as doubtful include assets for which there is a “distinct possibility” that a degree of loss will occur if the inadequacies are not corrected.
22
We evaluate whether a modification, extension or renewal of a loan is a current period origination in accordance with GAAP. Generally, loans up for renewal are subject to a full credit evaluation before the renewal is granted and such loans are considered current period originations for purpose of the table below. As of September 30, 2021, our loans based on year of origination and risk designation are as follows (dollars in thousands):
Term loans amortized cost basis by origination year
Revolving
2019
2018
2017
Prior
Loans
Pass
362,839
78,941
73,202
60,881
98,178
118,326
465,494
1,257,861
Special mention
904
5,653
4,198
13,787
24,767
Substandard
176
1,619
12,779
4,101
21,147
3,038
42,860
Doubtful
Total Commercial
363,015
75,046
74,564
107,932
143,671
482,319
Commercial Real Estate
1,178,056
587,923
446,299
479,741
514,973
944,052
171,963
4,323,007
3,364
1,875
4,335
26,550
6,633
42,757
1,942
4,500
657
18,861
36,112
8,790
70,862
Total Commercial Real Estate
1,179,998
592,423
450,320
500,477
519,308
1,006,714
187,386
Commercial Construction
1,405
7,370
37,492
2,600
2,247
490
486,404
538,008
14,888
Total Commercial Construction
501,292
Residential Real Estate
18,387
30,704
25,544
29,503
30,577
77,427
46,227
258,369
199
8,492
3,733
12,424
Total Residential Real Estate
29,702
85,919
49,960
96
50
26
35
1,761
125
Total Consumer
1,560,687
705,034
582,587
572,751
646,010
1,142,056
1,170,213
6,379,338
3,589
2,779
9,988
30,748
20,420
67,524
2,118
2,276
31,839
65,751
30,449
141,034
Grand Total
1,562,805
709,534
588,452
607,369
660,099
1,238,555
1,221,082
The following table presents information about the loan credit quality by loan class of gross loans (which exclude net deferred fees) as of December 31, 2020:
Special Mention
1,447,097
30,725
43,930
3,700,498
49,143
33,909
587,266
30,481
311,174
11,390
6,047,888
79,868
119,710
Collateral Dependent Loans: Loans which meet certain criteria are individually evaluated as part of the process of calculating the allowance for credit losses. The evaluation is determined on an individual basis using the fair value of the collateral as of the reporting date.
The following table presents collateral dependent loans that were individually evaluated for impairment as of September 30, 2021:
Real
Estate
6,778
26,175
32,953
56,622
12,582
10,258
86,240
112,415
24
Impaired loans - Impaired loans disclosures presented below as of December 31, 2020 and as of and for the three and nine months ended September 30, 2020 represent requirements prior to the adoption of CECL on January 1, 2021.
The following table provides an analysis of the impaired loans by class as of the year ended December 31, 2020:
Unpaid
Recorded
Principal
Related
Balance
No related allowance recorded
11,325
11,835
13,105
13,449
24,284
24,907
5,378
5,723
Total (no related allowance)
54,092
55,914
With an allowance recorded
23,736
69,122
12,985
1,329
Total (with allowance)
26,458
71,844
14,314
35,061
80,957
15,827
16,171
80,550
127,758
25
The following table provides an analysis related to the average recorded investment and interest income recognized on impaired loans by class as of and for the three months and nine months ended September 30, 2020 (dollars in thousands):
Average
Interest
Income
Recognized
Impaired loans (no allowance)
12,266
12,100
12,460
74
12,415
229
21,297
91
21,149
262
4,011
3,761
50,034
231
49,425
Impaired loans (allowance):
23,024
23,195
2,934
261
28,941
29,113
Total impaired loans:
35,290
35,295
15,182
15,137
24,231
24,083
4,272
4,023
78,975
236
78,538
662
Aging Analysis - The following table provides an analysis of the aging of the loans by class, excluding net deferred fees, that are past due as of September 30, 2021 and December 31, 2020 (dollars in thousands):
30-59 Days Past Due
60-89 Days Past Due
90 Days or Greater Past Due and Still Accruing
Total Past Due and Nonaccrual
Current
Gross Loans
391
417
4,463
35,750
1,289,738
Commercial real Estate
1,694
1,860
32,132
4,404,494
549,560
Residential real Estate
338
8,360
12,264
258,529
729
2,111
14,683
83,482
6,504,414
90 days or greater past due and still accruing category reflects purchased credit-deteriorated loans, net of fair value marks, which accrete income per the valuation at date of acquisition.
30-59 Days
Past Due
60-89 Days
90 Days or
Greater Past
Due and Still
Accruing
Total Past
Due and
Total Loans
Receivable
1,445
558
3,182
38,204
1,483,763
13,258
4,140
5,555
33,064
3,750,486
2,472
16,487
601,260
1,367
241
4,084
10,243
312,321
1,851
18,544
4,939
12,821
98,000
6,149,681
27
The following tables detail, at the period-end presented, the amount of gross loans (excluding loans held-for-sale) that are evaluated individually, and collectively, for impairment, those acquired with deteriorated quality, and the related portion of the ACL that are allocated to each loan portfolio segment:
Residential
real estate
construction
Individually evaluated for impairment
14,630
1,199
66
15,895
Collectively evaluated for impairment
9,487
40,222
3,702
3,302
56,721
Acquired with deteriorated credit quality individually analyzed
3,219
1,921
230
5,370
27,336
43,342
3,598
33,970
50,642
6,017
103,211
1,286,337
4,380,004
540,314
260,536
6,469,284
5,181
5,980
15,401
Unallocated
Allowance for loan losses
15,412
33,373
7,787
1,928
568
59,072
Acquired portfolio
46
4,628
407
759
5,840
Acquired with deteriorated credit quality
28,443
39,330
8,194
2,687
1,414,626
2,959,978
574,118
241,925
1,627
5,192,274
68,402
802,190
19,345
71,177
961,340
3,878
13,517
28
Activity in the Company’s ACL for loans for the three and nine months ended September 30, 2021 is summarized in the table below. Day 1 effect of CECL presented in the nine-months table below reflect adjustments recorded through retained earnings to adopt the CECL standard and the increase to the ACL for loans associated with nonaccretable purchase accounting marks on loans that were classified as PCI as of December 31, 2020.
Balance as of June 30, 2021
25,567
43,815
4,927
4,366
78,684
Charge-offs
(254
(1,473
(1,727
Recoveries
85
(Reversal of) provision for credit losses - loans
2,022
915
(1,225
(788
(8
916
Day 1 effect of CECL
(4,225
9,605
(961
2,697
(568
Balance as of January 1, 2021 as adjusted for changes in accounting principle
24,218
48,935
7,233
5,384
85,783
(304
(1,628
(1,939
188
Provision for (reversal of) credit losses - loans
3,348
(4,050
(3,531
(1,799
(14
(6,046
On January 1, 2021, the Company adopted CECL, which replaced the incurred loss method we used in prior periods for determining the provision for credit losses and the ACL. Under CECL, we record an expected loss of all cash flows we do not expect to collect at the inception of the loan. The adoption of CECL resulted in an increase in our ACL for loans of $6.6 million, which did not impact our consolidated income statement.
Balance as of June 30, 2020
9,345
22,655
8,026
1,690
27,003
68,724
(209
(257
800
14,861
16,623
(1,044
1,019
(26,457
24,158
40,078
6,982
2,500
546
74,267
8,349
20,853
7,304
1,685
99
38,293
(552
(278
(3
(833
802
807
16,359
18,423
(322
1,093
447
30
Troubled Debt Restructurings
Loans are considered to have been modified in a troubled debt restructuring (“TDR”) when, except as discussed below, due to a borrower’s financial difficulties, the Company makes certain concessions to the borrower that it would not otherwise consider. Modifications may include interest rate reductions, maturity extensions, principal or interest forgiveness, forbearance, and other actions intended to minimize economic loss and to avoid foreclosure or repossession of collateral. Generally, a nonaccrual loan that has been modified in a TDR remains on nonaccrual status for a period of nine months to demonstrate that the borrower is able to meet the terms of the modified loan. However, performance prior to the modification, or significant events that coincide with the modification, are included in assessing whether the borrower can meet the new terms and may result in the loan being returned to accrual status at the time of loan modification or after a shorter performance period. If the borrower’s ability to meet the revised payment schedule is uncertain, the loan remains on nonaccrual status.
As of September 30, 2021, there were no commitments to lend additional funds to borrowers whose loans were on nonaccrual status or were contractually past due 90 days or greater and still accruing interest, or whose terms have been modified in a TDR.
As of September 30, 2021, TDRs totaled $79.7 million, of which $38.5 million were on nonaccrual status and $41.2 million were classified as accruing and were performing under their restructured terms. As of December 31, 2020, TDRs totaled $49.4 million, of which $25.7 million were on nonaccrual status and $23.7 million were classified as accruing and were performing under their restructured terms. The Company has allocated $10.5 million and $4.4 million of specific allowance related to TDRs as of September 30, 2021 and September 30, 2020, respectively.
The following table presents loans by class modified as TDRs that occurred during the nine months ended September 30, 2021:
Pre-Modification Outstanding
Post-Modification Outstanding
Number of Loans
Recorded Investment
Troubled debt restructurings:
1,276
35,595
1,641
1,758
40,270
The loans modified as TDRs during the nine months ended September 30, 2021 included maturity extensions and interest rate reductions.
There were no loans modified as TDRs during the nine months ended September 30, 2020. There were no TDRs for which there was a payment default within twelve months following the modification during the three months ended and nine months ended September 30, 2021 and September 30, 2020.
In March 2020, various regulatory agencies, including the Board of Governors of the Federal Reserve System and the Federal Deposit Insurance Corporation, (“the agencies”) issued an interagency statement on loan modifications and reporting for financial institutions working with customers affected by COVID-19. The interagency statement was effective immediately and impacted accounting for loan modifications. The agencies confirmed with the staff of the FASB that short-term modifications made on a good faith basis in response to COVID-19 to borrowers who were current prior to any relief, are not to be considered TDRs. This includes short-term (e.g., three to nine months) modifications such as payment deferrals, fee waivers, extensions of repayment terms, or other delays in payment that are insignificant. Additionally, the statement allows for the Company to extend deferrals for an additional term at the option of the Company. Provisions of the CARES Act largely mirrored the provisions of the interagency statement, providing that modified loans would not be considered TDR’s if they were performing at year-end 2019, and the other conditions set forth in the interagency statement were met. Borrowers considered current are those that are less than 30 days past due on their contractual payments at the time a modification program is implemented or at year-end 2019. As of September 30, 2021, the Bank had 10 deferred loans totaling $10.3 million, compared to 113 deferred loans totaling $207.0 million as of December 31, 2020 that are not considered TDRs.
31
The following table sets forth the composition of these loans by loan segments as of September 30, 2021:
Principal Balance
10,297
As of September 30, 2021, there were no deferred loans that were delinquent or on nonaccrual status. As of September 30, 2021, $5.5 million of deferred loans were risk rated “special mention” or worse. The Company evaluates its deferred loans after the initial deferral period and will either return the deferred loan to its original loan terms or the loan will be reassessed at that time to determine if a further deferment should be granted and if a downgrade in risk rating is appropriate.
ACL for Unfunded Commitments
The Company has recorded an ACL for unfunded credit commitments, which was recorded in other liabilities. The provision is recorded within the (reversal of) provision for credit losses on the Company’s income statement. The following table presents the ACL for unfunded commitments for the three and nine months ended September 30, 2021 (dollars in thousands):
Balance as of beginning of period
2,380
Provision for (reversal of) credit losses - unfunded commitments
184
Balance as of end of period
2,564
Day 1 Effect of CECL
(269)
Components of (Reversal of) Provision for Credit Losses
The following table summarizes the provision for (reversal of) provision for credit losses for the three and nine months ended September 30, 2021 (dollars in thousands):
(6,046)
(6,315)
Note 6. Fair Value Measurements and Fair Value of Financial Instruments
Fair value is the exchange price that would be received for an asset or paid to transfer a liability (exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The following sets forth the hierarchy of valuation techniques used to determine fair value:
Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.
Level 2: Quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (for example, supported with little or no market activity).
An asset’s or liability’s level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The following information should not be interpreted as an estimate of the fair value of the entire Company since a fair value calculation is only provided for a limited portion of the Company’s assets and liabilities. Due to a wide range of valuation techniques and the degree of subjectivity used in making the estimates, comparisons between the Company’s disclosures and those of other companies may not be meaningful.
Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following methods and assumptions were used to estimate the fair values of the Company’s assets measured at fair value on a recurring basis as of September 30, 2021 and December 31, 2020:
Securities Available-for-Sale and Equity Securities: Where quoted prices are available in an active market, securities are classified within Level 1 of the valuation hierarchy. Level 1 inputs include securities that have quoted prices in active markets for identical assets. If quoted market prices are not available, then fair values are estimated by using pricing models, quoted prices of securities with similar characteristics, or discounted cash flows. Examples of instruments which would generally be classified within Level 2 of the valuation hierarchy include municipal bonds and certain agency collateralized mortgage obligations. In certain cases where there is limited activity in the market for a particular instrument, assumptions must be made to determine the fair value of the instruments and these are classified as Level 3. When measuring fair value, the valuation techniques available under the market approach, income approach and/or cost approach are used. The Company’s evaluations are based on market data and the Company employs combinations of these approaches for its valuation methods depending on the asset class.
Derivatives: The fair value of derivatives is based on valuation models using observable market data as of the measurement date (level 2). Our derivatives are traded in an over-the-counter market where quoted market prices are not always available. Therefore, the fair values of derivatives are determined using quantitative models that utilize multiple market inputs. The inputs will vary based on the type of derivative, but could include interest rates, prices and indices to generate continuous yield or pricing curves, prepayment rate, and volatility factors to value the position. The majority of market inputs are actively quoted and can be validated through external sources, including brokers, market transactions and third-party pricing services.
33
Note 6. Fair Value Measurements and Fair Value of Financial Instruments – (continued)
For financial assets and liabilities measured at fair value on a recurring basis, the fair value measurements by level within the fair value hierarchy used as of September 30, 2021 and December 31, 2020 are as follows:
Fair Value Measurements at Reporting Date Using
Total Fair Value
Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)
Significant
Observable
Inputs
(Level 2)
Unobservable
(Level 3)
Recurring fair value measurements:
Investment securities:
Available-for-sale:
Obligations of U.S. states and political subdivision
121,638
8,636
Total available-for-sale
453,228
11,709
1,991
Derivatives
1,296
477,880
12,729
456,515
34
133,964
8,844
478,954
501,342
13,544
Liabilities
(2,119)
There were no transfers between Level 1 and Level 2 during the nine months ended September 30, 2021 and during the year ended December 31, 2020.
Assets Measured at Fair Value on a Nonrecurring Basis
The Company may be required periodically to measure certain assets at fair value on a nonrecurring basis in accordance with GAAP. These adjustments to fair value usually result from the application of lower of cost or fair value accounting or impairment write-downs of individual assets. The following methods and assumptions were used to estimate the fair values of the Company’s assets measured at fair value on a nonrecurring basis as of September 30, 2021 and December 31, 2020.
Loans Held-for-Sale: Residential mortgage loans, originated and intended for sale in the secondary market, are carried at the lower of aggregate cost or estimated fair value as determined by outstanding commitments from investors. For these loans originated and intended for sale, gains and losses on loan sales (sale proceeds minus carrying value) are recorded in other income and direct loan origination costs and fees are deferred at origination of the loan and are recognized in other income upon sale of the loan. Management obtains quotes or bids on all or parts of these loans directly from the purchasing financial institutions (Level 2).
Other loans held-for-sale are carried at the lower of aggregate cost or estimated fair value. Fair value of these loans is determined based on the terms of the loan, such as interest rate, maturity date, reset term, as well as sales of similar assets (Level 3).
Collateral Dependent Loans: The Company may record adjustments to the carrying value of loans based on fair value measurements, either as specific reserves or as partial charge-offs of the uncollectible portions of these loans. These adjustments also include certain impairment amounts for collateral dependent loans calculated in accordance with GAAP. Impairment amounts are generally based on the fair value of the underlying collateral supporting the loan and, as a result, the carrying value of the loan less the calculated impairment amount applicable to that loan does not necessarily represent the fair value of the loan. Real estate collateral is valued using independent appraisals or other indications of value based on recent comparable sales of similar properties or assumptions generally observable by market participants. However, due to the substantial judgment applied and limited volume of activity as compared to other assets, fair value is based on Level 3 inputs. Estimates of fair value used for collateral supporting commercial loans generally are based on assumptions not observable in the marketplace and are also based on Level 3 inputs.
For assets measured at fair value on a nonrecurring basis, the fair value measurements as of September 30, 2021 and December 31, 2020 are as follows:
Quoted
Prices
Assets measured at fair value on a nonrecurring
basis:
Collateral dependent loans:
12,966
16,407
2,251
Collateral dependent loans – Collateral dependent loans as of September 30, 2021 that required a valuation allowance were $48.2 million with a related valuation allowance of $16.6 million.
Impaired loans:
10,751
1,393
Impaired loans – Impaired loans as of December 31, 2020 that required a valuation allowance were $26.5 million with a related valuation allowance of $14.3 million
36
Assets Measured With Significant Unobservable Level 3 Inputs
Recurring basis
The tables below present a reconciliation of all assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the nine months ended September 30, 2021 and for the year ended December 31, 2020:
Municipal
Securities
Principal paydowns
(208
9,114
(270)
The following methods and assumptions were used to estimate the fair values of the Company’s assets measured at fair value on a recurring basis as of September 30, 2021 and December 31, 2020. The table below provides quantitative information about significant unobservable inputs used in fair value measurements within Level 3 hierarchy.
Valuation
Techniques
Input
Rate
Municipal securities
Discounted cash flows
Discount rate
2.9
%
37
Nonrecurring basis: The following methods and assumptions were used to estimate the fair values of the Company’s assets measured at fair value on a nonrecurring basis for the periods presented. The tables below provide quantitative information about significant unobservable inputs used in fair value measurements within Level 3 hierarchy.
Range (weighted average)
Collateral dependent:
780
Appraisals of collateral value
Comparable sales
0% - 5% (2%)
12,186
Market approach (100)
Average transfer price as a price to unpaid principal balance
48 – 53 (49)
0% - 25% (8%)
1% - 15% (6%)
Range (weighed average)
10,524
Market approach (100%)
48 - 53 (49)
Adjustment for comparable sales
1% to +5% (+2%)
-25% to +20% (-8%)
38
As of September 30, 2021 the fair value measurements presented are consistent with Topic 820, Fair Value Measurement, in which fair value represents exit price. The following presents the carrying amount, fair value, and placement in the fair value hierarchy of the Company’s financial instruments as of September 30, 2021 and December 31, 2020:
Fair Value Measurements
Prices in
Active
Carrying
Financial assets:
Investment in restricted stocks
n/a
Net loans
6,567,363
1,356
32,254
Financial liabilities:
Noninterest-bearing deposits
Interest-bearing deposits
4,899,141
3,675,673
1,223,468
255,099
Subordinated debentures
164,378
Accrued interest payable
2,879
Investment securities available-for-sale
Restricted investment in bank stocks
6,244,037
1,764
33,553
4,633,961
3,155,983
1,477,978
429,671
214,113
2,119
3,687
39
The fair value of commitments to originate loans is estimated using the fees currently charged to enter into similar agreements, considering the remaining terms of the agreements and the present creditworthiness of the counterparties. For fixed-rate loan commitments, fair value also considers the difference between current levels of interest rates and the committed rates. The fair values of letters of credit and lines of credit are based on fees currently charged for similar agreements or on the estimated cost to terminate or otherwise settle the obligations with the counterparties at the reporting date. The fair value of commitments to originate loans is immaterial and not included in the tables above.
Changes in assumptions or estimation methodologies may have a material effect on these estimated fair values.
Fair value estimates are based on existing balance sheet financial instruments, without attempting to estimate the value of anticipated future business and the value of assets and liabilities that are not considered financial instruments. For example, there are certain significant assets and liabilities that are not considered financial assets or liabilities, such as deferred taxes, premises and equipment, and goodwill. In addition, the tax ramifications related to the realization of the unrealized gains and losses can have a significant effect on fair value estimates and have not been considered in the estimates.
Management believes that reasonable comparability between financial institutions may not be likely, due to the wide range of permitted valuation techniques and numerous estimates which must be made, given the absence of active secondary markets for many of the financial instruments. This lack of uniform valuation methodologies also introduces a greater degree of subjectivity to these estimated fair values.
Note 7. Comprehensive Income
Total comprehensive income includes all changes in equity during a period from transactions and other events and circumstances from non-owner sources. The Company’s other comprehensive income is comprised of unrealized holding gains and losses on securities available-for-sale, unrealized gains (losses) on cash flow hedges, obligations for defined benefit pension plan and an adjustment to reflect the curtailment of the Company’s defined benefit pension plan, each net of taxes.
The following table represents the reclassification out of accumulated other comprehensive (loss) income for the periods presented:
Details about Accumulated Other
Comprehensive Income Components
Amounts Reclassified from Accumulated
Other Comprehensive Income
Affected Line item in the
Statement Where Net Income is Presented
Sale of investment securities
Net (losses) gains on sales of securities available-for-sale Income tax expense
available-for-sale
Net interest income on swaps
(328
(631
(1,543
(942
90
196
434
265
(238
(435
(1,109
(677
Amortization of pension plan net
(75
(225
(226
actuarial losses
63
Income tax benefit
(54
(162
(163
Total reclassification
(292
(489
(1,124
(817
40
Note 7. Comprehensive Income – (continued)
Accumulated other comprehensive income (loss) as of September 30, 2021 and December 31, 2020 consisted of the following:
Investment securities available-for-sale, net of tax
1,475
7,859
Cash flow hedge, net of tax
932
(1,520
Defined benefit pension plan, net of tax
(3,380
(3,542
Note 8. Stock Based Compensation
The Company’s stockholders approved the 2017 Equity Compensation Plan (“the Plan”) on May 23, 2017. The Plan eliminates all remaining issuable shares under previous plans and is the only outstanding plan as of September 30, 2021. The maximum number of shares of common stock or equivalents which may be issued under the Plan, is 750,000. Grants under the Plan can be in the form of stock options (qualified or non-qualified), restricted shares, restricted share units or performance units. Shares available for grant and issuance under the Plan as of September 30, 2021 are approximately 329,175. The Company intends to issue all shares under the Plan in the form of newly issued shares.
Restricted stock, options and restricted stock units typically have a three-year vesting period starting one year after the date of grant with one-third vesting each year or upon a change-in-control. The options generally expire ten years from the date of grant. Restricted stock granted to new employees and board members may be granted with shorter vesting periods. Grants of performance units typically have a cliff vesting after three years or upon a change-in-control. All issuances are subject to forfeiture if the recipient leaves or is terminated prior to the awards vesting. Restricted shares have the same dividend and voting rights as common stock, while options, performance units and restricted stock units do not.
All awards are issued at the fair value of the underlying shares at the grant date. The Company expenses the cost of the awards, which is determined to be the fair market value of the awards at the date of grant, ratably over the vesting period. Forfeiture rates are not estimated but are recorded as incurred. Stock-based compensation expense for the three and nine months ended September 30, 2021 was $1.2 million and $3.2 million, respectively. Stock-based compensation expense for the three and nine months ended September 30, 2020 was $0.8 million and $2.0 million, respectively.
Activity in the Company’s options for the nine months ended September 30, 2021 was as follows:
Number of
Options
Weighted-
Exercise
Price
Remaining
Contractual
Term
(in years)
Aggregate
Intrinsic Value
Outstanding as of December 31, 2020
38,013
9.03
Granted
Exercised
(5,449
8.34
Forfeited/cancelled/expired
Outstanding as of September 30, 2021
32,564
9.15
1.0
554,374
Exercisable as of September 30, 2021
The aggregate intrinsic value of outstanding and exercisable options above represents the total pre-tax intrinsic value (the difference between the Company’s closing stock price on September 30, 2021 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on September 30, 2021. This amount changes based on the fair market value of the Company’s stock.
41
Note 8. Stock Based Compensation – (continued)
Activity in the Company’s restricted shares for the nine months ended September 30, 2021 was as follows:
Nonvested
Grant Date
Shares
Nonvested as of December 31, 2020
113,114
18.17
49,971
25.33
Vested
(68,142
17.16
(3,071
23.76
Nonvested September 30, 2021
91,872
22.62
As of September 30, 2021, there was approximately $1.4 million of total unrecognized compensation cost related to nonvested restricted shares granted. The cost is expected to be recognized over a weighted average period of 1.2 years.
A summary of the status of unearned performance unit awards and the change during the period is presented in the table below:
Weighted
Average Grant
Units
Date Fair
(expected)
(maximum)
Unearned as of December 31, 2020
147,636
17.29
Awarded
37,543
25.24
Change in estimate
37,184
15.57
Vested shares
(29,421
31.35
(11,153
17.06
Unearned as of September 30, 2021
181,789
233,638
16.32
As of September 30, 2021, the specific number of shares related to performance units that were expected to vest was 181,789, determined by actual performance in consideration of the established range of the performance targets, which is consistent with the level of expense currently being recognized over the vesting period. Should this expectation change, additional compensation expense could be recorded in future periods or previously recognized expense could be reversed. As of September 30, 2021 the maximum amount of performance units that ultimately could vest if performance targets were exceeded is 233,638. During the nine months ended September 30, 2021, 29,421 shares vested. A total of 14,710 shares were netted from the vested shares to satisfy employee tax obligations. The net shares issued from vesting of performance units during the nine months ended September 30, 2021 were 14,711 shares. As of September 30, 2021, compensation cost of approximately $1.4 million related to non-vested performance units not yet recognized is expected to be recognized over a weighted-average period of 1.6 years.
A summary of the status of unearned restricted stock units and the changes in restricted stock units during the period is presented in the table below:
Date Fair Value
169,313
14.07
45,027
(68,916
16.29
(8,476
15.83
136,948
16.52
Any forfeitures would result in previously recognized expense being reversed. A portion of the shares that vest will be netted out to satisfy the tax obligations of the recipient. During the nine months ended September 30, 2021, 68,916 shares vested. A total of 34,458 shares were netted from the vested shares to satisfy employee tax obligations. The net shares issued from vesting of restricted stock units during the nine months ended September 30, 2021 were 34,458 shares. As of September 30, 2021, compensation cost of approximately $1.4 million related to non-vested restricted stock units, not yet recognized, is expected to be recognized over a weighted-average period of 1.3 years.
Note 9. Components of Net Periodic Pension Cost
The Company maintained a non-contributory defined benefit pension plan for substantially all of its employees until September 30, 2007, at which time the Company froze the plan. The following table sets forth the net periodic pension cost of the Company’s pension plan for the periods indicated.
Affected Line Item in the Consolidated
Statements of Income
Service cost
Interest cost
71
Expected return on plan assets
(213
Net amortization
Total periodic pension income
213
273
(588
Contributions
The Company did not contribute to the Pension Trust during the nine months ended September 30, 2021. The Company does not plan on contributing amounts to the Pension Trust for the remainder of 2021. The trust is established to provide retirement and other benefits for eligible employees and their beneficiaries. No part of the trust assets may be applied to any purpose other than providing benefits under the plan and for defraying expenses of administering the plan and the trust.
43
Note 10. FHLB Borrowings
The Company’s FHLB borrowings and weighted average interest rates are summarized below:
Total FHLB borrowings
1.23
1.07
By remaining period to maturity:
Less than 1 year
168,213
1.00
297,570
0.84
1 year through less than 2 years
57,360
1.93
75,644
1.42
2 years through less than 3 years
50,000
1.84
3 years through less than 4 years
25,000
4 years through 5 years
2,050
2.23
After 5 years
2.91
2,824
2.42
253,352
426,038
Fair value discount
(127
(84
FHLB borrowings, net
The FHLB borrowings are secured by pledges of certain collateral including, but not limited to, U.S. government and agency mortgage-backed securities and a blanket assignment of qualifying first lien mortgage loans, consisting of both residential mortgages and commercial real estate loans.
Advances are payable at stated maturity, with a prepayment penalty for fixed rate advances. All FHLB advances are fixed rates. The advances as of September 30, 2021 were primarily collateralized by approximately $2.0 billion of commercial mortgage loans, net of required over collateralization amounts, under a blanket lien arrangement. As of September 30, 2021 the Company had remaining borrowing capacity of approximately $1.2 billion at FHLB and $75 million of the less than 1 year FHLB advances were hedged with interest rate swaps, see Note 4 for additional details.
Note 11. Subordinated Debentures
During December 2003, Center Bancorp Statutory Trust II, a statutory business trust and wholly owned subsidiary of the Parent Corporation issued $5.0 million of MMCapS capital securities to investors due on January 23, 2034. The trust loaned the proceeds of this offering to the Company and received in exchange $5.2 million of the Parent Corporation’s subordinated debentures. The subordinated debentures are redeemable in whole or part. The floating interest rate on the subordinated debentures is three-month LIBOR plus 2.85% and re-prices quarterly. The rate as of September 30, 2021 was 2.98%.
The following table summarizes the mandatory redeemable trust preferred securities of the Company’s Statutory Trust II as of September 30, 2021 and December 31, 2020.
Issuance Date
Issued
Liquidation Value
Coupon Rate
Maturity
Redeemable by
Issuer Beginning
12/19/2003
$ 5,000,000
$1,000 per Capital Security
Floating 3-month LIBOR + 285 Basis Points
01/23/2034
01/23/2009
44
Note 11. Subordinated Debentures – (continued)
During September 2020, the Parent Corporation issued $75 million in aggregate principal amount of fixed-to-floating rate subordinated notes (the “2020 Notes”). The 2020 Notes bear interest at 5.75% annually from, and including, the date of initial issuance to, but excluding, September 15, 2025 or the date of earlier redemption, payable semi-annually in arrears on September 15 and December 15 of each year, commencing December 15, 2020. From and including September 15, 2025 through maturity or earlier redemption, the interest rate shall reset quarterly to an interest rate per annum equal to a benchmark rate, which is expected to be Three-Month Term SOFR (as defined in the Second Supplemental Indenture), plus 560.5 basis points, payable quarterly in arrears on March 15, June 15, September 15 and December 15 of each year, commencing on September 15, 2025. Notwithstanding the foregoing, if the benchmark rate is less than zero, then the benchmark rate shall be deemed to be zero.
During January 2018, the Parent Corporation issued $75 million in aggregate principal amount of fixed-to-floating rate subordinated notes (the “Notes”) to certain accredited investors. The net proceeds from the sale of the Notes were used in the first quarter of 2018 for general corporate purposes, which included the Parent Corporation contributing $65 million of the net proceeds to the Bank in the form of debt and common equity. The Notes are non-callable for five years, have a stated maturity of February 1, 2028 and bear interest at a fixed rate of 5.20% per year, from and including January 17, 2018 to, but excluding February 1, 2023. From and including February 1, 2023 to, but excluding the maturity date, or early redemption date, the interest rate will reset quarterly to a level equal to the then current three-month LIBOR rate plus 284 basis points.
During September 2015, the Parent Corporation issued $50 million in aggregate principal amount of fixed-to-floating rate subordinated notes (the “2015 Notes”). As of December 31, 2020, the 2015 Notes have a stated maturity of July 1, 2025, and bear interest until the maturity date or early redemption date at a variable rate equal to the then current three-month LIBOR rate plus 393 basis points. As of December 31, 2020, the variable interest rate was 4.16% and all costs related to 2015 issuance have been amortized. The 2015 Notes were redeemed in full on January 1, 2021.
Note 12. Preferred Stock
On August 19, 2021, the Company completed an underwritten public offering of 115,000 shares, or $115 million in aggregate liquidation preference, of its 5.25% Fixed-Rate Non-Cumulative Perpetual Preferred Stock, Series A, no par value, with a liquidation preference of $1,000 per share. The net proceeds received from the issuance of preferred stock at the time of closing were $110.9 million.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The purpose of this analysis is to provide the reader with information relevant to understanding and assessing the Company’s results of operations for the periods presented herein and financial condition as of September 30, 2021 and December 31, 2020. In order to fully understand this analysis, the reader is encouraged to review the consolidated financial statements and accompanying notes thereto appearing elsewhere in this report.
Cautionary Statement Concerning Forward-Looking Statements
This report includes forward-looking statements within the meaning of Sections 27A of the Securities Act of 1933, as amended, and 21E of the Securities Exchange Act of 1934, as amended, that involve inherent risks and uncertainties. This report contains certain forward-looking statements with respect to the financial condition, results of operations, plans, objectives, future performance and business of ConnectOne Bancorp Inc. and its subsidiaries, including statements preceded by, followed by or that include words or phrases such as “believes,” “expects,” “anticipates,” “plans,” “trend,” “objective,” “continue,” “remain,” “pattern” or similar expressions or future or conditional verbs such as “will,” “would,” “should,” “could,” “might,” “can,” “may” or similar expressions. There are a number of important factors that could cause future results to differ materially from historical performance and these forward-looking statements. Factors that might cause such a difference include, but are not limited to: (1) competitive pressures among depository institutions may increase significantly; (2) changes in the interest rate environment may reduce interest margins; (3) prepayment speeds, loan origination and sale volumes, charge-offs and loan loss provisions may vary substantially from period to period; (4) general economic conditions may be less favorable than expected; (5) political developments, sovereign debt problems, wars or other hostilities may disrupt or increase volatility in securities markets or other economic conditions; (6) legislative or regulatory changes or actions may adversely affect the businesses in which ConnectOne Bancorp is engaged; (7) changes and trends in the securities markets may adversely impact ConnectOne Bancorp; (8) a delayed or incomplete resolution of regulatory issues could adversely impact planning by ConnectOne Bancorp; (9) the impact on reputation risk created by the developments discussed above on such matters as business generation and retention, funding and liquidity could be significant; (10) the outcome of regulatory and legal investigations and proceedings may not be anticipated, and (11) the impact of the COVID-19 pandemic on our employees and operations, and those of our customers. Further information on other factors that could affect the financial results of ConnectOne Bancorp is included in Item 1a. of ConnectOne Bancorp’s Annual Report on Form 10-K as amended and updated in ConnectOne Bancorp’s other filings with the Securities and Exchange Commission. These documents are available free of charge at the Commission’s website at http://www.sec.gov and/or from ConnectOne Bancorp, Inc.
Critical Accounting Policies and Estimates
The accounting and reporting policies followed by ConnectOne Bancorp, Inc. and its subsidiaries (collectively, the “Company”) conform, in all material respects, to GAAP. In preparing the consolidated financial statements, management has made estimates, judgments and assumptions that affect the reported amounts of assets and liabilities as of the dates of the consolidated statements of condition and for the periods indicated in the consolidated statements of income. Actual results could differ significantly from those estimates.
The Company’s accounting policies are fundamental to understanding Management’s Discussion and Analysis (“MD&A”) of financial condition and results of operations. The Company has identified the determination of the ACL, the other-than-temporary impairment evaluation of securities, the evaluation of the impairment of goodwill and the evaluation of deferred tax assets to be critical because management must make subjective and/or complex judgments about matters that are inherently uncertain and could be most subject to revision as new information becomes available. Additional information on these policies is provided below.
Allowance for Credit Losses and Related Provision: The ACL represents management’s estimate of current expected credit losses considering available information relevant to assessing collectability of cash flows over the contractual term of the financial asset(s). Determining the amount of the ACL is considered a critical accounting estimate because it requires significant judgment and the use of estimates including reasonable and supportable forecasts that affect the collectability of the remaining cash flows over the contractual term of the financial assets.
The evaluation of the adequacy of the ACL includes, among other factors, an analysis of historical loss rates by loan segment applied to current loan totals. However, actual credit losses may be higher or lower than historical trends, which vary. Actual losses on specified problem loans, which also are provided for in the evaluation, may vary from estimated loss percentages, which are established based upon a limited number of potential loss classifications.
The ACL is established through a provision for credit losses charged to expense. Management believes that the current ACL will be adequate to absorb current expected credit losses on existing loans that may become uncollectible based on the evaluation of known and inherent risks in the loan portfolio. The evaluation takes into consideration such factors as changes in the nature and size of the portfolio, overall portfolio quality, and specific problem loans and current economic conditions which may affect the borrowers’ ability to pay. The evaluation also details historical losses by loan segment and the resulting credit loss rates which are projected for current loan total amounts. Loss estimates for specified problem loans are also detailed. All of the factors considered in the analysis of the adequacy of the ACL may be subject to change. To the extent actual outcomes differ from management estimates, additional provisions for credit losses may be required that could materially adversely impact earnings in future periods. Additional information can be found in Note 5 of the Notes to Consolidated Financial Statements.
Business Combinations: We account for business combinations under the acquisition method of accounting. Using this method, assets acquired, liabilities assumed and consideration paid are recorded at their estimated fair values as of the acquisition date. The application of this method of accounting requires the use of significant estimates and assumptions. The application of the acquisition method of accounting usually results in the recognition of goodwill and a core deposit intangible (if the acquiree has deposits). The amount of goodwill recorded represents the excess purchase price over the estimated fair value of the net assets acquired, including any identifiable intangibles, if applicable. Goodwill is not amortized for book purposes; however, it is reviewed at least annually for impairment and is usually not deductible for tax purposes.
The assets acquired and liabilities assumed and consideration paid in the acquisition are recorded at their estimated fair values based on management’s best estimates using information available at the date of the acquisition and are subject to adjustment for up to one year after the closing date of the acquisition. Our estimates are based upon assumptions that we believe to be reasonable and the Company may use an outside service provider to assist with the valuations.
Goodwill: The Company adopted the provisions of FASB ASC 350-10, which requires that goodwill be reported separate from other intangible assets in the Consolidated Statements of Condition and not be amortized but rather tested for impairment annually or more frequently if impairment indicators arise. The Company performs an annual goodwill impairment test in the fourth quarter of each year, or more often if events or circumstances warrant. We will continue to monitor and evaluate the impact of COVID-19 and its impact on our market capitalization, overall economic conditions and any other potential triggering events that may indicate an impairment of goodwill in the future. In the event we conclude that all or a portion of our goodwill is impaired, a non-cash charge for the amount of such impairment would be recorded to earnings. Such a charge would have no impact on tangible capital or our regulatory capital ratios.
Income Taxes: The objectives of accounting for income taxes are to recognize the amount of taxes payable or refundable for the current year and deferred tax liabilities and assets for the future tax consequences of events that have been recognized in an entity’s financial statements or tax returns. Judgment is required in assessing the future tax consequences of events that have been recognized in the Company’s consolidated financial statements or tax returns.
Fluctuations in the actual outcome of these future tax consequences could impact the Company’s consolidated financial condition or results of operations. Note 11 of the Notes to Consolidated Financial Statements included in the Company’s Form 10-K for the year ended December 31, 2020 includes additional discussion on the accounting for income taxes.
Impact of COVID-19
COVID-19 continues to impact the Company’s operations and financial results, as well as those of our customers. In response to the COVID-19 pandemic, the Company continued to offer temporary relief to effected customers, deferring either their full loan payment, the principal component or the interest component of their loan payment for an initial period of time ranging from 30 to 120 days. As of September 30, 2021, the Company has 10 deferred loans with a total outstanding loan balance of $10.2 million. As provided for under the CARES Act, these short-term deferrals are not considered troubled debt restructurings, provided that the modification is related to COVID-19, executed on a loan that was not more than 30 days past due as of December 31, 2019 or the date of the deferral, and executed between March 1, 2020 and January 1, 2022, or the date that is 60 days after the termination date of the national emergency declared by the President on March 13, 2020, under the National Emergencies Act related to the outbreak of COVID-19.
With the passage of the Paycheck Protection Program (“PPP”), administered by the Small Business Administration (“SBA”), the Company was an active participant in assisting its customers with applications for resources through the program. PPP loans originated prior to September 5, 2020 have a two-year term, which may be extended to five years with the consent of the Company, and those originated on or after September 5, 2020 have a five-year term, and the loans bear interest at 1%, along with an origination fee payable from the SBA to the Company. The Company believes that the majority of these loans will ultimately be forgiven by the SBA in accordance with the terms of the program. As of September 30, 2021, PPP loans were $177.8 million. It is the Company’s understanding that loans funded through the PPP program are fully guaranteed by the U.S. government and, as such, the Company has not included the PPP loans in calculation of the ACL as of September 30, 2021. Should those circumstances change, the Company could be required to establish additional provisions for credit loss expense charged to earnings. As of September 30, 2021, remaining deferred and unrecognized PPP fees were $6.0 million. We currently anticipate recognizing a majority of this balance by December 31, 2022, reflecting the expected timing of PPP loan forgiveness granted by the Small Business Administration.
Operating Results Overview
Net income for the three months ended September 30, 2021 was $32.1 million, compared to $24.8 million for the three-month period ended September 30, 2020. The Company’s diluted earnings per share were $0.80 for the three months ended September 30, 2021, compared with diluted earnings per share of $0.62 for the three-month period ended September 30, 2020. The increase in net income and diluted earnings per share was attributable to an increase in net interest income of $7.7 million, a decrease in provision for credit losses of $3.9 million, and an increase in noninterest income of $0.5 million, partially offset by an increase in noninterest expenses of $1.7 million and an increase in income tax expense of $3.1 million. The decrease in provision for credit losses, to $1.1 million, was due to the impact of an improved economic outlook on the current expected credit losses (“CECL”) accounting standard, compared with a $5.0 million provision in the third quarter of 2020.
Net income for the nine months ended September 30, 2021 was $97.3 million compared to $45.6 million for the comparable nine-month period ended September 30, 2020. The Company’s diluted earnings per share were $2.43 for the nine months ended September 30, 2021, compared with diluted earnings per share of $1.15 for the comparable nine-month period ended September 30, 2020. The increase in net income and diluted earnings per share were primarily attributable to an increase in net interest income of $15.8 million, a decrease in provision for credit losses of $42.3 million, a decrease in noninterest expenses of $13.7 million and an increase in noninterest income of $1.0 million, partially offset by an increase in income tax expense of $21.1 million. The $6.3 million reversal of provision for loan losses was due to the impact of an improved economic outlook on the CECL accounting standard, compared with a $36.0 million provision in the nine months ended September 30, 2020, which reflected the impact of the pandemic estimated under the incurred loss method.
Net Interest Income and Margin
Net interest income is the difference between the interest earned on the portfolio of earning assets (principally loans and investments) and the interest paid for deposits and borrowings, which support these assets. Net interest income is presented on a tax-equivalent basis by adjusting tax-exempt income (primarily interest earned on obligations of state and political subdivisions) by the amount of income tax which would have been paid had the assets been invested in taxable issues. Net interest margin is defined as net interest income on a tax-equivalent basis as a percentage of total average interest-earning assets.
Fully taxable equivalent net interest income for the three months ended September 30, 2021 increased by $7.8 million, or 12.7%, from the comparable three-month period ended September 30, 2020. The increase from the third quarter of 2020 resulted primarily from a 24 basis-point widening of the net interest margin to 3.73% from 3.49%, and an increase of 5.2% in average interest-earning assets. The widening of the net interest margin resulted from a 60 basis-point reduction in the cost of interest-bearing liabilities, partially offset by 24 basis-points reduction in the yield on average interest-earning assets.
Fully taxable equivalent net interest income for the nine months ended September 30, 2021 increased by $15.8 million, or 8.8%, from the comparable nine-month period ended September 30, 2020, resulting from an increase in average interest-earning assets of 3.3%, largely due to PPP originations, and a 19 basis-point widening of the net interest margin to 3.63% from 3.44%. The widening of the net interest margin resulted from a 62 basis-point reduction in the cost of interest-bearing liabilities, partially offset by a 33 basis-point reduction in the yield on average interest-earning assets.
The following tables, “Average Statements of Condition with Interest and Average Rates”, present for the three and nine months ended September 30, 2021 and 2020, the Company’s average assets, liabilities and stockholders’ equity. The Company’s net interest income, net interest spread and net interest margin are also reflected.
Average Statements of Condition with Interest and Average Rates
49
Income/
Expense
Rate (7)
Federal funds sold and interest-bearing deposits
with banks
332,290
285
0.11
244,539
0.34
Interest-bearing liabilities:
Noninterest Income
Noninterest income totaled $4.0 million for the three months ended September 30, 2021, compared with $3.5 million for the comparable three-month period ended September 30, 2020. The increase of $0.5 million in noninterest income when compared to the third quarter of 2020 was attributable to increases in sale of loans held-for-sale of $0.5 million and deposit, loan and other income of $0.4 million, partially offset by a decrease in BOLI of $0.3 million and a net loss on equity securities of $0.1 million.
Noninterest income totaled $11.9 million for the nine months ended September 30, 2021, compared with $11.0 million for the comparable nine-month period ended September 30, 2020. Included in noninterest income for the nine months ended September 30, 2021 and September 30, 2020 were $0.9 million and $2.3 million, respectively, of PPP loan referral fee income generated by BoeFly. Also included in noninterest income for the nine months ended September 30, 2021 was $0.7 million on a gain on sale of branches and a $0.2 million gain on sale/redemption of investment securities. Excluding these items, noninterest income increased by $1.8 million when compared to the comparable nine-month period ended September 30, 2020. The increase was primarily attributable to an increase in net gains on sale of loans held-for-sale of $1.4 million and an increase in deposit, loan and other income of $1.0 million, partially offset by decreases in BOLI income of $0.2 million and an increase in net losses on equity securities of $0.5 million.
Noninterest Expenses
Noninterest expenses totaled $28.2 million for the three months ended September 30, 2021, compared with $26.5 million for the comparable three-month period ended September 30, 2020. Noninterest expenses increased $1.7 million when compared to the comparable three-month period ended September 30, 2020. The increase was primarily attributable to increases in salaries and employee benefits of $1.6 million, other expenses of $1.2 million, professional and consulting expenses of $0.3 million, marketing and advertising $0.1 million and data processing expenses of $0.1 million, partially offset by decreases in occupancy and equipment expenses of $0.9 million, FDIC insurance expense of $0.6 million and amortization of core deposit intangibles of $0.1 million.
Noninterest expenses totaled $80.9 million for the nine months ended September 30, 2021, compared with $94.6 million for the comparable nine-month period ended September 30, 2020. Included in noninterest expenses for the nine months ended September 30, 2020 were $14.6 million in merger and restructuring expenses and $2.3 million in expenses related to the BoeFly acquisition. Excluding these items, noninterest expenses increased $3.3 million when compared to the comparable nine-month period ended September 30, 2020. The increase was primarily attributable to increases in salaries and employee benefits of $3.5 million, other expenses of $1.5 million, professional and consulting expenses of $1.1 million and data processing expenses of $0.2 million, partially offset by decreases in occupancy and equipment expense of $1.3 million, FDIC insurance expense of $1.0 million, amortization of core deposit intangibles of $0.4 million and marketing and advertising expense of $0.1 million.
Income Taxes
Income tax expense was $10.9 million for the three months ended September 30, 2021, compared to $7.8 million for the comparable three-month period ended September 30, 2020. The increase in income tax expense was the result of higher income before taxes. The effective tax rate for the three months ended September 30, 2021 and September 30, 2020 was 25.3% and 23.9%, respectively. The higher effective tax rate during the third quarter 2021 when compared to the third quarter of 2020 resulted from a lower proportion of income from non-taxable sources.
Income tax expense was $32.4 million for the nine months ended September 30, 2021, compared to $11.3 million for comparable nine-month period ended September 30, 2020. The increase in income tax expense was the result of higher income before taxes. The effective tax rate for the nine months ended September 30, 2021 was 25.0% versus 19.9% for the prior-year period. The higher effective tax rate during the third quarter of 2021 when compared to the third quarter of 2020 resulted from a lower proportion of income from non-taxable sources.
51
Financial Condition
Loan Portfolio
The following table sets forth the composition of our loan portfolio, excluding loans held-for-sale and unearned net origination fees and costs, by loan segment at the periods indicated.
(1) Included in commercial loans as of September 30, 2021 and December 31, 2020 were PPP loans of $177.8 million and $397.5 million, respectively.
As of September 30, 2021, gross loans totaled $6.6 billion, an increase of $340.2 million, or 5.4%, as compared to December 31, 2020. Net loan growth was primarily attributable to increases in the commercial real estate segment of $653.1 million, offset by decreases in the commercial segment of $196.5 million, which primarily resulted from PPP loan forgiveness, decreases in commercial construction of $64.9 million and decreases in residential real estate of $51.8 million.
Allowance for Credit Losses and Related Provision
As of January 1, 2021, the Company adopted the CECL accounting standard. As of September 30, 2021, the Company’s ACL for loans was $78.0 million, a decrease of $1.2 million from $79.2 million December 31, 2020. The decrease was attributable to a release of credit losses of approximately $6.0 million, net charge-offs of $1.8 million, partially offset by a provision of $6.6 million resulting from the “Day 1” effect of the adoption of the CECL accounting.
The provision for (reversal of) credit losses, which includes provision for unfunded commitments, for the three and nine months ended September 30, 2021 was $1.1 million and $(6.3) million, respectively, compared to $5.0 million and $36.0 million, for the three and nine months ended September 30, 2020, respectively. The decrease in provision for credit losses was the result of an improved macroeconomic outlook as of September 30, 2021 when compared to January 1, 2021, the day the Company adopted CECL. The prior year provision in the three and nine months ended September 30, 2020, was primarily due to the significant economic slowdown due to the COVID-19 pandemic.
There were $1.6 million and $1.8 million in net loan charge-offs during the three and nine months ended September 30, 2021, compared with $(0.5) million and $-0- in net loan recoveries during the three and nine months ended September 30, 2020, respectively. The current quarter included a $1.4 million charge-off of a commercial real estate loan that previously had a specific credit reserve. The ACL as a percentage of loans receivable was to 1.19% as of September 30, 2021 compared to 1.27% as of December 31, 2020. Excluding the impact of PPP loans in the calculation of the ACL as a percentage of loans receivable, the ratio is 1.22% as of September 30, 2021, compared to 1.36% as of December 31, 2020. PPP loans do not have allowance for credit losses attributable to them, as they are assumed to be fully guaranteed by the SBA.
The level of the ACL for the respective periods of 2021 and allowance for loan losses for 2020 reflects the credit quality within the loan portfolio, loan growth, the changing composition of the commercial and residential real estate loan portfolios and other related factors. In management’s view, the level of the ACL as of September 30, 2021 is adequate to cover expected credit losses inherent in the loan portfolio. Management’s judgment regarding the adequacy of the allowance constitutes a “Forward-Looking Statement” under the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from management’s analysis, based principally upon the factors considered by management in establishing the allowance.
52
Changes in the ACL are presented in the following table for the periods indicated.
(1) The ACL for the prior periods was calculated based on the incurred loan loss model.
53
Asset Quality
The Company manages asset quality and credit risk by maintaining diversification in its loan portfolio and through review processes that include analysis of credit requests and ongoing examination of outstanding loans, delinquencies, and potential problem loans, with particular attention to portfolio dynamics and mix. The Company strives to identify loans experiencing difficulty early enough to correct the problems, to record charge-offs promptly based on realistic assessments of current collateral values and cash flows, and to maintain an adequate allowance for loan losses at all times.
It is generally the Company’s policy to discontinue interest accruals once a loan is past due as to interest or principal payments for a period of ninety days. When a loan is placed on nonaccrual status, interest accruals cease and uncollected accrued interest is reversed and charged against current income. Payments received on nonaccrual loans are generally applied against principal. A loan may be restored to an accruing basis when all past due amounts have been collected. Loans past due 90 days or more which are both well-secured and in the process of collection may remain on an accrual basis.
Nonperforming assets include nonaccrual loans and other real estate owned. Nonaccrual loans represent loans on which interest accruals have been suspended. In general, it is the policy of management to consider the charge-off of uncollectible amounts of loans at the point they become past due 90 days. Performing troubled debt restructured loans represent loans to borrowers experiencing financial difficulties on which a concession was granted, such as a reduction in interest rate below the current market rate for new debt with similar risks or modified repayment terms and are performing under the restructured terms.
The following table sets forth, as of the dates indicated, the amount of the Company’s nonaccrual loans, other real estate owned (“OREO”), performing troubled debt restructurings (“TDRs”) and loans past due 90 days or greater and still accruing:
During the nine months ended September 30, 2021, the Bank designated approximately $40.7 million as TDRs. The increase in that designation was mainly attributable to maturity extensions and interest rate reductions in the commercial real estate segment. The majority of these loans were previously on deferment, and were subsequently designated TDRs once the deferral periods ended.
As of September 30, 2021, the principal components of the securities portfolio were federal agency obligations, mortgage-backed securities, obligations of U.S. states and political subdivisions, corporate bonds and notes, asset-backed securities and equity securities. For the three months ended September 30, 2021, average securities increased by $39.2 million to approximately $459.6 million, or 6.3% of average total interest-earning assets, from approximately $420.4 million, or 6.0% of average interest-earning assets, for the comparable period in 2020.
As of September 30, 2021, net unrealized gains on securities available-for-sale, which are carried as a component of accumulated other comprehensive income and included in stockholders’ equity, net of tax, amounted to $1.5 million as compared with net unrealized gains of $7.9 million as of December 31, 2020. The decrease in unrealized gains is predominately attributable to changes in market conditions and interest rates. Unrealized losses have not been recognized into income because the issuers are of high credit quality, we do not intend to sell, and it is likely that we will not be required to sell the securities prior to their anticipated recovery. The decline in fair value is largely due to changes in interest rates and other market conditions. The issuers continue to make timely principal and interest payments on the securities. Any impairment that has not been recorded through an allowance for credit losses is recognized in other comprehensive income, net of applicable taxes. The Company did not record an ACL for available-for-sale as of September 30, 2021.
Interest Rate Sensitivity Analysis
The principal objective of our asset and liability management function is to evaluate the interest-rate risk included in certain balance sheet accounts; determine the level of risk appropriate given our business focus, operating environment, and capital and liquidity requirements; establish prudent asset concentration guidelines; and manage the risk consistent with Board approved guidelines. We seek to reduce the vulnerability of our operations to changes in interest rates, and actions in this regard are taken under the guidance of the Bank’s Asset Liability Committee (the “ALCO”). The ALCO generally reviews our liquidity, cash flow needs, maturities of investments, deposits and borrowings, and current market conditions and interest rates.
We currently utilize net interest income (“NII”) simulation and economic value of equity (“EVE”) models to measure the potential impact to the Bank of future changes in interest rates. As of September 30, 2021 and December 31, 2020, the results of the models were within guidelines prescribed by our Board of Directors. If model results were to fall outside prescribed ranges, action, including additional monitoring and reporting to the Board, would be required by the ALCO and the Bank’s management.
The net interest income simulation model attempts to measure the change in net interest income over the next one-year period, and over the next three-year period on a cumulative basis, assuming certain changes in the general level of interest rates.
Based on our model, which was run as of September 30, 2021, we estimated that over the next one-year period a 200 basis-point instantaneous increase in the general level of interest rates would increase our net interest income by 3.23%, while a 100 basis-point instantaneous decrease in interest rates would decrease net interest income by 5.80%. As of December 31, 2020, we estimated that over the next one-year period a 200 basis-point instantaneous increase in the general level of interest rates would increase our net interest income by 0.70%, while a 100 basis-point instantaneous decrease in interest rates would decrease net interest income by 5.18%.
Based on our model, which was run as of September 30, 2021, we estimated that over the next three years, on a cumulative basis, a 200 basis-point instantaneous increase in the general level of interest rates would increase our net interest income by 9.39%, while a 100 basis-point instantaneous decrease in interest rates would decrease net interest income by 10.72%. As of December 31, 2020, we estimated that over the next three years, on a cumulative basis, a 200 basis-point instantaneous increase in the general level of interest rates would increase our net interest income by 3.89%, while a 100 basis-point instantaneous decrease in interest rates would decrease net interest income by 8.56%.
An EVE analysis is also used to dynamically model the present value of asset and liability cash flows with instantaneous rate shocks of up 200 basis points and down 100 basis points. The economic value of equity is likely to be different as interest rates change. Our EVE as of September 30, 2021, would decline by 0.61% with an instantaneous rate shock of up 200 basis points, and decrease by 1.30% with an instantaneous rate shock of down 100 basis points. Our EVE as of December 31, 2020, would decline by 7.76% with an instantaneous rate shock of up 200 basis points, and increase by 5.70% with an instantaneous rate shock of down 100 basis points.
The following table illustrates the most recent results for EVE and one-year NII sensitivity as of September 30, 2021.
55
Estimates of Fair Value
The estimation of fair value is significant to a number of the Company’s assets, including loans held-for-sale and securities available-for-sale. These are all recorded at either fair value or the lower of cost or fair value. Fair values are volatile and may be influenced by a number of factors. Circumstances that could cause estimates of the fair value of certain assets and liabilities to change include a change in prepayment speeds, discount rates, or market interest rates. Fair values for most available-for-sale securities are based on quoted market prices. If quoted market prices are not available, fair values are based on judgments regarding future expected loss experience, current economic condition risk characteristics of various financial instruments, and other factors. These estimates are subjective in nature, involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates.
Impact of Inflation and Changing Prices
The consolidated financial statements and notes thereto presented elsewhere herein have been prepared in accordance with GAAP, which requires the measurement of financial position and operating results in terms of historical dollars without considering the change in the relative purchasing power of money over time due to inflation. The impact of inflation is reflected in the increased cost of operations; unlike most industrial companies, nearly all of the Company’s assets and liabilities are monetary. As a result, interest rates have a greater impact on performance than do the effects of general levels of inflation. Interest rates do not necessarily move in the same direction or to the same extent as the prices of goods and services.
Liquidity
Liquidity is a measure of a bank’s ability to fund loans, withdrawals or maturities of deposits, and other cash outflows in a cost-effective manner. Our principal sources of funds are deposits, scheduled amortization and prepayments of loan principal, maturities of investment securities, and funds provided by operations. While scheduled loan payments and maturing investments are relatively predictable sources of funds, deposit flow and loan prepayments are greatly influenced by general interest rates, economic conditions and competition.
As of September 30, 2021, the amount of liquid assets remained at a level management deemed adequate to ensure that, on a short and long-term basis, contractual liabilities, depositors’ withdrawal requirements, and other operational and client credit needs could be satisfied. As of September 30, 2021, liquid assets (cash and due from banks, interest-bearing deposits with banks and unencumbered investment securities) were $800.4 million, which represented 10.1% of total assets and 12.0% of total deposits and borrowings, compared to $697.4 million as of December 31, 2020, which represented 9.2% of total assets and 10.9% of total deposits and borrowings.
The Bank is a member of the Federal Home Loan Bank of New York and, based on available qualified collateral as of September 30, 2021, had the ability to borrow $2.0 billion. In addition, as of September 30, 2021, the Bank had in place borrowing capacity of $25.0 million through correspondent banks. The Bank also has a credit facility established with the Federal Reserve Bank of New York for direct discount window borrowings with capacity based on pledged collateral of $3.1 million. As of September 30, 2021, the Bank had aggregate available and unused credit of approximately $1.2 billion, which represents the aforementioned facilities totaling $2.0 billion net of $760.3 million in outstanding borrowings and letters of credit. As of September 30, 2021, outstanding commitments for the Bank to extend credit were approximately $1.2 billion.
Cash and cash equivalents totaled $413.2 million as of September 30, 2021, increasing by $109.4 million from $303.8 million as of December 31, 2020. Operating activities provided $154.6 million in net cash. Investing activities used $352.7 million in net cash, primarily reflecting an increase in loans. Financing activities provided $307.5 million in net cash, primarily reflecting a net increase in deposits of $440.9 million, net proceeds raised from the issuance of preferred stock of $110.9 million and a decrease in net borrowings of $172.7 million.
56
The following table sets forth the composition of our deposit base by the periods indicated.
Subordinated Debentures
During December 2003, Center Bancorp Statutory Trust II, a statutory business trust and wholly-owned subsidiary of the Parent Corporation issued $5.0 million of MMCapS capital securities to investors due on January 23, 2034. The trust loaned the proceeds of this offering to the Company and received in exchange $5.2 million of the Parent Corporation’s subordinated debentures. The subordinated debentures are redeemable in whole or part prior to maturity. The floating interest rate on the subordinated debentures is three-month LIBOR plus 2.85% and re-prices quarterly. The rate as of September 30, 2021 was 2.98%.
During January 2018, the Parent Corporation issued $75 million in aggregate principal amount of fixed-to-floating rate subordinated notes (the “2018 Notes”) to certain accredited investors. The net proceeds from the sale of the 2018 Notes were used for general corporate purposes, which included the Parent Corporation contributing $65 million of the net proceeds to the Bank in the form of debt and common equity in the first quarter of 2018. The 2018 Notes are non-callable for five years, have a stated maturity of February 1, 2028 and bear interest at a fixed rate of 5.20% per year, from and including January 17, 2018 to, but excluding February 1, 2023. From and including February 1, 2023 to, but excluding the maturity date, or early redemption date, the interest rate will reset quarterly to a level equal to the then current three-month LIBOR rate plus 284 basis points.
During September 2015, the Parent Corporation issued $50 million in aggregate principal amount of fixed-to-floating rate subordinated notes (the “2015 Notes”). As of December 31, 2020, the 2015 Notes had a stated maturity of July 1, 2025, and bore interest until the maturity date or early redemption date at a variable rate equal to the then current three-month LIBOR rate plus 393 basis points. As of December 31, 2020, the variable interest rate was 4.16% and all costs related to 2015 issuance have been amortized. The 2015 Notes were redeemed in full on January 1, 2021.
57
Stockholders’ Equity
The Company’s stockholders’ equity was $1.1 billion as of September 30, 2021, an increase of $183.1 million from December 31, 2020. In August 2021, the Company raised $110.9 million, net of estimated issuance expenses, from the issuance of $115 million in 5.25% fixed rate, non-cumulative, perpetual preferred stock. This issuance is primarily reason for the overall increase in stockholders’ equity, coupled with increases in retained earnings of $82.0 million and additional paid-in capital of $2.0 million, partially offset by a decrease in accumulated other comprehensive income of $3.8 million and an increase in treasury stock of $8.0 million. As of September 30, 2021, the Company’s tangible common equity ratio and tangible book value per share were 9.95% and $19.43, respectively. As of December 31, 2020, the tangible common equity ratio and tangible book value per share were 9.50% and $17.49, respectively. Total goodwill and other intangible assets were approximately $217.9 million as of September 30, 2021 and $219.3 million as of December 31, 2020.
Common stock outstanding as of period end
Book value per common share
58
Regulatory Capital and Capital Adequacy
The maintenance of a solid capital foundation is a primary goal for the Company. Accordingly, capital plans, stock repurchases and dividend policies are monitored on an ongoing basis. The Company’s objective with respect to the capital planning process is to effectively balance the retention of capital to support future growth with the goal of providing stockholders with an attractive long-term return on their investment.
The Company and the Bank are subject to regulatory guidelines establishing minimum capital standards that involve quantitative measures of assets, and certain off-balance sheet items, as risk-adjusted assets under regulatory accounting practices.
The following is a summary of regulatory capital amounts and ratios as of September 30, 2021 for the Company and the Bank, compared with minimum capital adequacy requirements and the regulatory requirements for classification as a well-capitalized depository institution.
For Capital Adequacy
Purposes
To Be Well-Capitalized Under
Prompt Corrective Action
Provisions
N/A - not applicable
As of September 30, 2021, both the Company and Bank satisfy the capital conservation buffer requirements applicable to them. The lowest ratio as measured against the capital conservation buffers, at the Company was the CET1 Risk Based Ratio, which was 3.73% above the minimum buffer ratio, and, at the Bank was the Total Risk Based Capital Ratio, which was 3.11% above the minimum buffer ratio.
59
Item 3. Qualitative and Quantitative Disclosures about Market Risks
Market Risk
Interest rate risk management is our primary market risk. See "Item 2- Management's Discussion and Analysis of Financial Condition and Results of Operations - Interest Rate Sensitivity Analysis" herein for a discussion of our management of our interest rate risk.
Item 4. Controls and Procedures
a) Disclosure controls and procedures. As of the end of the Company’s most recently completed fiscal quarter covered by this report, the Company carried out an evaluation, with the participation of the Company’s management, including the Company’s chief executive officer and chief financial officer, of the effectiveness of the Company’s disclosure controls and procedures pursuant to Securities Exchange Act Rule 13a-15. Based upon that evaluation, the Company’s chief executive officer and chief financial officer concluded that the Company’s disclosure controls and procedures are effective in ensuring that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms and are operating in an effective manner and that such information is accumulated and communicated to management, including the Company’s chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure.
b) Changes in internal controls over financial reporting. There have been no changes in the Company’s internal controls over financial reporting that occurred during the Company’s last fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
60
PART II – OTHER INFORMATION
Item 1. Legal Proceedings
The Company is not subject to any legal proceedings, which could have a materially adverse impact on its results of operations and financial condition.
Item 1a. Risk Factors
There have been no material changes to the risks inherent in our business from those described under Item 1A – Risk Factors of our Annual Report on Form 10-K for the year ended December 31, 2020.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
See “Item 2- Management’s Discussion and Analysis of Financial Condition and Results of Operations – Shareholders’ Equity”
Item 3. Defaults Upon Senior Securities
Not applicable
Item 4. Mine Safety Disclosures
Item 5 Other Information
61
Item 6. Exhibits
3.1
4.1
Specimen of the Company’s 5.25% Fixed Rate Reset Non-Cumulative Perpetual Preferred Stock, Series A Certificate (incorporated herein by reference to Exhibit 4.1 to the Company’s Registration Statement on Form 8-A, filed on August 19, 2021). (1)
4.2
Deposit Agreement, dated as of August 19, 2021, among the Company, Broadridge Corporate Issuer Solutions, Inc., as depositary, and the holders from time to time of the depositary receipts described therein (1)
31.1
Certification of the Chief Financial Officer of the Parent Corporation Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Certification of the Chief Executive Officer of the Parent Corporation Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
Certification of the Chief Financial Officer of the Parent Corporation Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
62
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf, by the undersigned, thereunto duly authorized.
(Registrant)